Health testing and diagnostics platform

ABSTRACT

Systems and methods for providing a universal platform for at-home health testing and diagnostics are provided herein. In particular, a health testing and diagnostic platform is provided to connect medical providers with patients and to generate a unique, private testing environment. In some embodiments, the testing environment may facilitate administration of a medical test to a patient with the guidance of a proctor. In some embodiments, the patient may be provided with step-by-step instructions for test administration by the proctor within a testing environment. The platform may display unique, dynamic testing interfaces to the patient and proctor to ensure proper testing protocols and accurate test result verification.

INCORPORATION BY REFERENCE TO ANY PRIORITY APPLICATIONS

Any and all applications for which a foreign or domestic priority claimis identified in the Application Data Sheet as filed with the presentapplication are hereby incorporated by reference under 37 CFR 1.57. Thisapplication is a continuation of U.S. application Ser. No. 17/452,746,entitled “HEALTH TESTING AND DIAGNOSTICS PLATFORM,” filed Oct. 28, 2021,which is a continuation of U.S. application Ser. No. 17/452,726,entitled “HEALTH TESTING AND DIAGNOSTICS PLATFORM,” filed Oct. 28, 2021,which claims the benefit under 35 U.S.C. 119(e) to U.S. ProvisionalApplication No. 63/136,575, entitled “HEALTH TESTING AND DIAGNOSTICSPLATFORM,” filed Jan. 12, 2021, to U.S. Provisional Application No.63/156,012, entitled “HEALTH TESTING AND DIAGNOSTICS PLATFORM,” filedMar. 3, 2021, and to U.S. Provisional Application 63/179,864, entitled“HEALTH TESTING AND DIAGNOSTICS PLATFORM,” filed Apr. 26, 2021, each ofwhich is hereby incorporated by reference herein.

BACKGROUND Field

Some embodiments of the present disclosure are directed to systems andmethods for conducting remote health testing and diagnostics.

Description

Use of telehealth to deliver health care services has grown consistentlyover the last several decades, and has exploded in usage during theCoronavirus disease 2019 (COVID-19) Public Health Emergency (PHE).Telehealth is the distribution of health-related services andinformation via electronic information and telecommunicationtechnologies. Telehealth allows long-distance patient and healthprovider contact, care, advice, reminders, education, intervention,monitoring, and remote admissions. In situations such as the COVID-19PHE, when many medical and hospital resources are devoted to treatingthe sick, patients are more reluctant to travel to their health providerin-person, and when access to care is restricted, telehealth provides aninvaluable resource.

During the COVID-19 pandemic, testing for coronavirus disease (COVID-19)was extremely limited in various places throughout the world, includingthe United States. Tracing infected individuals was and continues to bean important step in preventing new cases of infectious diseases. Inresponse, the United States Food and Drug Administration (FDA) hasauthorized various at-home COVID-19 tests.

At-home testing solves some of the problems with in-person testing. Forexample, health insurance may not be required, travel to a testing siteis avoided, and tests can be completed at a patient's convenience.However, at-home testing introduces various additional logistical andtechnical issues, such as guaranteeing timely test delivery to apatient's home, providing test delivery from a patient to an appropriatelab, ensuring test verification and integrity, providing test resultreporting to appropriate authorities and medical providers, andconnecting patients with medical providers, who are needed to provideguidance and/or oversight of the testing procedures remotely. Theseissues are not unique to COVID-19 and will need to be addressed inrelation to remote health diagnostic testing generally. Therefore, anovel health and diagnostic platform, which solves the issues associatedwith at-home health testing, is needed.

SUMMARY

For purposes of this summary, certain aspects, advantages, and novelfeatures of the invention are described herein. It is to be understoodthat not all such advantages necessarily may be achieved in accordancewith any particular embodiment of the invention. Thus, for example,those skilled in the art will recognize that the invention may beembodied or carried out in a manner that achieves one advantage or groupof advantages as taught herein without necessarily achieving otheradvantages as may be taught or suggested herein.

Health testing and diagnostics platforms are provided herein that canfacilitate proctored at-home testing. Users performing at home testingmay be guided or assisted by proctors that are available over acommunication network. The platform can be optimized such that proctorscan supervise the at-home tests of a plurality of users. In someembodiments, users that have gained experience and proficiency with theplatform and the at-home tests may be eligible for expedited or expressproctoring sessions. Such platforms can, for example, greatly increasethe availability of testing, and reduce the spread of infectiousdiseases, and increase the efficiency of proctors in terms of increasingthe number of patients that a proctor can simultaneously monitor.

In a first aspect, a computer-implemented system for a proctoredexamination platform for a medical diagnostic test is described. Thecomputer-implemented system comprises an electronic storage comprisingcomputer-executable instructions and one or more processors inelectronic communication with the electronic storage medium andconfigured to execute the computer-executable instructions in order to:receive, by the computing system from a user device of a user incommunication with the computing system over an electronic network, arequest for a proctored examination session for a medical diagnostictest; based on the request, establish, by the computing system, theproctored examination session between the user device of the user and aproctor device of a proctor over the electronic network; receive, by thecomputing system, image data from at least one imaging device of theuser device, the image data comprising at least a view of the user or atleast one testing material of a test kit for the medical diagnostictest; identify, by the computing system, at least one feature within theimage data received from the imaging device of the user device, the atleast one feature comprising at least one of an anatomical feature ofthe user or at least one testing feature of the at least one testingmaterial of the test kit; generate, by the computing system, userdisplay data for display to the user on a user graphical user interfaceon a display of the user device, the user display data comprising atleast: the image data received from the at least one imaging device ofthe user device, and at least one computer-generated graphic associatedwith the identified at least one feature within the image data, whereinthe at least one computer-generated graphic is overlaid onto the imagedata at a position associated with at least one identified feature, andthe at least one computer-generated graphic is configured to facilitateat least one step of the medical diagnostic test; generate, by thecomputing system, proctor display data for display to the proctor on aproctor graphical user interface on a display of the proctor device, theproctor display data comprising at least the image data received fromthe imaging device of the user device and information associated withthe medical diagnostic test; transmit, from the computing system overthe electronic network, the user display data to the user device fordisplay on the user graphical user interface on the display of the userdevice; and transmit, from the computing system, the proctor displaydata to the proctor device for display on the proctor graphical userinterface on the display of the proctor device; whereby the userperforms the at least one step of the medical diagnostic test based onthe user display data and the proctor monitors performance of the atleast one step of the medical diagnostic test based on the proctordisplay data.

The system can include one or more of the following features in anycombination: (a) wherein the proctor display data further comprises theat least one computer-generated graphic associated with the identifiedat least one feature within the image data, wherein the at least onecomputer-generated graphic is overlaid onto the image data at a positionassociated with at least one identified feature, and the at least onecomputer-generated graphic configured to facilitate at least one step ofthe medical diagnostic test; (b) wherein identifying the at least onefeature within the image data received from the imaging device of theuser device comprises analyzing, by the computing system, the image datausing a computer vision algorithm configured to detect the at least onefeature within the image data; (c) wherein transmitting the user displaydata to the user device and transmitting the proctor display data to theproctor device occur substantially simultaneously such that the user andthe proctor view the image data in a substantially synchronized state;(d) wherein the at least one feature within the image data comprises anostril of the user; (e) wherein the at least one feature within theimage data comprises a test swab; (f) wherein the at least one featurewithin the image data comprises a portion of a testing material to whicha testing solution is to be introduced by the user; (g) wherein theinformation associated with the medical diagnostic test of the proctordisplay data comprises an indication of a current testing step of themedical diagnostic test; (h) wherein the information associated with themedical diagnostic test of the proctor display data comprises a testinginstruction to be read to the user by the proctor; (i) wherein theproctored testing session comprises an electronic video conferencesession between the user device and proctor device; (j) wherein the usercomprises a first user, the image data comprises first image data, andthe computer-implemented system is further configured to receive, by thecomputing system from a second user device of a second user incommunication with the computing system over the electronic network, asecond request for a second proctored examination session for a secondmedical diagnostic test; based on the second request for the secondproctored examination session for the second medical diagnostic test,establish the second proctored examination session between the seconduser device of the second user and the proctor device of the proctorover the electronic network; receive, at the computing system, secondimage data from at least one second imaging device of the second userdevice, the second image data comprising at least a second view of thesecond user or at least one second testing material of a second test kitof the second medical diagnostic test; identify, by the computingsystem, at least one second feature within the second image datareceived from the second imaging device of the second user device, theat least one second feature comprising at least one of an anatomicalfeature of the second user or at least one testing feature of the atleast one second testing material of the second test kit; generate, bythe computing system, second user display data for display to the seconduser on a second user graphical user interface on a second display ofthe second user device, the second user display data comprising atleast: the second image data received from the at least one secondimaging device of the second user device, and at least one secondcomputer-generated graphic associated with the identified at least onesecond feature within the second image data, wherein the at least onesecond computer-generated graphic is overlaid onto the second image dataat a position associated with at least one identified second feature,and the at least one second computer-generated graphic is configured tofacilitate at least one step of the second medical diagnostic test;generate, by the computing system, second proctor display data fordisplay to the proctor on the proctor graphical user interface on thedisplay of the proctor device, the second proctor display datacomprising at least the second image data received from the imagingdevice of the second user device and second information associated withthe second medical diagnostic test; transmit, from the computing systemover the electronic network, the second user display data to the seconduser device for display on the second user graphical user interface onthe display of the second user device; and transmit, from the computingsystem, the second proctor display data to the proctor device fordisplay on the proctor graphical user interface on the display of theproctor device; whereby the second user performs the at least one stepof the medical diagnostic test aided by the second user display data andthe proctor monitors performance of the at least one step of the secondmedical diagnostic test aided by the second proctor display data; (k)wherein the proctor graphical user interface is configured to displaythe first proctor display data and the second proctor display data atthe same time such that the proctor monitors the first user and thesecond user at the same time; and/or other features as describedthroughout this application.

In another aspect, a computer-implemented system for a multi-sessionproctored examination platform for a medical diagnostic test isdescribed. The computer-implemented system comprises: an electronicstorage medium of a computing system, the electronic storage mediumcomprising computer-executable instructions; one or more processors ofthe computing system, the one or more processors in electroniccommunication with the electronic storage medium, the one or moreprocessors in electronic communication through an electronic networkwith a first user computing device and a second user computing device,the one or more processors configured to execute the computer-executableinstructions stored in the electronic storage medium for implementingthe multi-session proctored examination platform for the medicaldiagnostic test by: receiving, by the computing system, through theelectronic network a first user request from a first user for aproctored examination at a first time, the first user request receivedfrom the first user computing device; generating, by the computingsystem, display data for displaying a graphical user interface (GUI) ona display of a proctor device, the display data configured to display toa proctor a first set of two or more phases of the medical diagnostictest and a first phase indicator showing a current phase of the firstuser in the two or more phases of the medical diagnostic test;transmitting, by the computing system, through the electronic networkthe display data to the proctor device; receiving, by the computingsystem, through the electronic network a first video conferenceconnection request from the proctor device; establishing, by thecomputing system, a first electronic video conference session betweenthe proctor device and the first user computing device; receiving, bythe computing system, through the electronic network a second userrequest from a second user for a proctored examination at a second time,the second user request received from the second user computing device,wherein the second time is later in time than the first time;generating, by the computing system, supplemental display data fordisplaying the graphical user interface (GUI) on the display of theproctor device, the supplemental display data configured to concurrentlydisplay: the first set of two or more phases of the medical diagnostictest and a second phase indicator showing the current phase of the firstuser in the first set of two or more phases of the medical diagnostictest, and a second set of two or more phases of the medical diagnostictest and a third phase indicator showing the current phase of the seconduser in the second set of two or more phases of the medical diagnostictest, wherein the second and third phase indicators are at differentphases in the two or more phases of the medical diagnostic test;transmitting, by the computing system, through the electronic networkthe supplemental display data to the proctor device; receiving, by thecomputing system, through the electronic network a first videoconference connection termination request and a second video conferenceconnection request from the proctor device; terminating, by thecomputing system, the first electronic video conference session betweenthe proctor device and the first user computing device; transmitting, bythe computing system, through the electronic network to the first usercomputing device content data configured to be displayed on the firstuser computing device; and establishing, by the computing system, asecond electronic video conference session between the proctor deviceand the second user computing device.

The system may include one or more of the following features in anycombination: (a) wherein the content data comprises augmented realitycontent data for showing the first user how to administer the medicaldiagnostic test; (b) wherein the content data comprises virtual realitycontent data for showing the first user how to administer the medicaldiagnostic test; (c) the proctor can simultaneously conduct the secondvideo conference session with the second user while monitoring the firstuser that is viewing the content data; (d) wherein the monitoring thefirst user that is viewing the content data comprises transmitting, bythe computer system, through the electronic network to the proctordevice video data of the first user to ensure that the first user iswatching the content data; (e) analyzing, by the computing system, usinga computer vision algorithm the video data to detect a medicaldiagnostic test device and to determine if the medical diagnostic testdevice has moved, and transmitting, by the computing system, through theelectronic network, based on determining that the medical diagnostictest device has moved, an alert notification to the proctor device tonotify the proctor that the medical diagnostic test device has moved;(f) receiving, by the computing system, through the electronic network amute request from the proctor device to mute the proctor for the secondelectronic video conference session, and an unmute request from theproctor device to unmute the proctor associated with the video databeing transmitted to the first user; (g) wherein the third phaseindicator is in an earlier phase relative to the second phase indicator;(h) the computing system comprises one or more computing systems; (i)wherein the supplemental display data configured to concurrently displaythe first set of two or more phases of the medical diagnostic test andthe second set of two or more phases of the medical diagnostic testenables the proctor to monitor multiple medical diagnostic test sessionsfor multiple users; and/or other features as described throughout thisapplication.

In another aspect, a computer-implemented method for a multi-sessionproctored examination platform for one or more medical diagnostic tests,the computer-implemented is described. The method comprises: receiving,by the computing system, through an electronic network a first userrequest from a first user for a proctored examination at a first time,the first user request received from a first user computing device;generating, by the computing system, display data for displaying agraphical user interface (GUI) on a display of a proctor device, thedisplay data configured to display to a proctor a first set of two ormore phases of a first medical diagnostic test and a first phaseindicator showing a current phase of the first user in the two or morephases of the first medical diagnostic test; transmitting, by thecomputing system, through the electronic network the display data to theproctor device; receiving, by the computing system, through theelectronic network a first video conference connection request from theproctor device; establishing, by the computing system, a firstelectronic video conference session between the proctor device and thefirst user computing device; receiving, by the computing system, throughthe electronic network a second user request from a second user for aproctored examination at a second time, the second user request receivedfrom a second user computing device, wherein the second time is later intime than the first time; generating, by the computing system,supplemental display data for displaying the graphical user interface(GUI) on the display of the proctor device, the supplemental displaydata configured to concurrently display: the first set of two or morephases of the first medical diagnostic test and a second phase indicatorshowing the current phase of the first user in the first set of two ormore phases of the first medical diagnostic test, and a second set oftwo or more phases of a second medical diagnostic test and a third phaseindicator showing the current phase of the second user in the second setof two or more phases of the second medical diagnostic test, wherein thesecond and third phase indicators are at different phases in the two ormore phases of the first and second medical diagnostic tests;transmitting, by the computing system, through the electronic networkthe supplemental display data to the proctor device; receiving, by thecomputing system, through the electronic network a second videoconference connection request from the proctor device; terminating, bythe computing system, a video feed from the proctor device in the firstelectronic video conference session between the proctor device and thefirst user computing device; and establishing, by the computing system,a second electronic video conference session between the proctor deviceand the second user computing device, wherein the computing systemcomprises one or more computer processors and an electronic memory.

The system may include one or more of the following features in anycombination: (a) transmitting, by the computing system, through theelectronic network to the first user computing device a content datacomprising augmented reality content data for showing the first user howto administer the first medical diagnostic test; (b) transmitting, bythe computing system, through the electronic network to the first usercomputing device a content data comprises virtual reality content datafor showing the first user how to administer the first medicaldiagnostic test; (c) wherein the proctor can simultaneously conduct thesecond video conference session with the second user while monitoringthe first user through the first electronic video conference session;(d) wherein the monitoring the first user comprises transmitting, by thecomputer system, through the electronic network to the proctor devicevideo data of the first user to ensure that the first user is presentduring the first medical diagnostic test; (e) analyzing, by thecomputing system, using a computer vision algorithm the video data todetect a medical diagnostic test device and to determine if the medicaldiagnostic test device has moved, and transmitting, by the computingsystem, through the electronic network, based on determining that themedical diagnostic test device has moved, an alert notification to theproctor device to notify the proctor that the medical diagnostic testdevice has moved; (f) receiving, by the computing system, through theelectronic network a mute request from the proctor device to mute theproctor for the second electronic video conference session, and anunmute request from the proctor device to unmute the proctor for thefirst electronic video conference session; (g) wherein the third phaseindicator is in an earlier phase relative to the second phase indicator;(h) wherein the computing system comprises one or more computingsystems; (i) wherein the supplemental display data configured toconcurrently display the first set of two or more phases of the firstmedical diagnostic test and the second set of two or more phases of thesecond medical diagnostic test enables the proctor to monitor multiplemedical diagnostic test sessions for multiple users; and/or otherfeatures as described throughout this application.

BRIEF DESCRIPTION OF THE DRAWINGS

The drawings are provided to illustrate example embodiments and are notintended to limit the scope of the disclosure. A better understanding ofthe systems and methods described herein will be appreciated uponreference to the following description in conjunction with theaccompanying drawings, wherein:

FIG. 1 illustrates an example flowchart of an at-home testing protocolaccording to some embodiments described herein.

FIG. 2 illustrates an example flowchart of a method for registering auser and ordering a diagnostic test for an at home-testing protocolaccording to some embodiments described herein.

FIG. 3 illustrates an example flowchart of an on-demand testing protocolwith a proctor according to some embodiments described herein.

FIG. 4 illustrates an example flowchart of a method of reporting testingresults according to some embodiments described herein.

FIG. 5 illustrates an example diagram of a health card according to someembodiments described herein.

FIG. 6 illustrates an example flowchart for a proctor certification andtesting protocol according to some embodiments described herein.

FIG. 7 illustrates an example flowchart for providing urgent care to apatient via a health testing and diagnostic platform according to someembodiments described herein.

FIG. 8 illustrates an example pre-testing confirmation interfaceaccording to some embodiments described herein.

FIG. 9 illustrates an example pre-testing virtual waiting room accordingto some embodiments described herein.

FIG. 10 illustrates an example unique code submission interfaceaccording to some embodiments described herein.

FIG. 11 illustrates an example patient testing interface according tosome embodiments described herein.

FIG. 12 illustrates another example patient testing interface accordingto some embodiments described herein.

FIG. 13 illustrates an example test initiation interface according tosome embodiments described herein.

FIG. 14 illustrates an example pre-testing interface according to someembodiments described herein.

FIG. 15A illustrates an example testing interface according to someembodiments described herein.

FIG. 15B illustrates another example testing interface according to someembodiments described herein.

FIG. 16 illustrates an example test analysis and interpretationinterface according to some embodiments described herein.

FIG. 17 illustrates another example test analysis and interpretationinterface according to some embodiments described herein.

FIG. 18 illustrates an example another example testing interfaceaccording to some embodiments described herein.

FIG. 19 illustrates an example testing summary interface according tosome embodiments described herein.

FIG. 20 illustrates an example test distribution interface according tosome embodiments described herein.

FIG. 21 illustrates an example multi-session management interfaceaccording to some embodiments described herein.

FIG. 22 illustrates an example testing dashboard interface according tosome embodiments described herein.

FIG. 23 illustrates an example multi-session testing interface accordingto some embodiments described herein.

FIG. 24 illustrates another example multi-session testing interfaceaccording to some embodiments described herein.

FIG. 25A illustrates another example multi-session testing interfaceaccording to some embodiments described herein.

FIG. 25B illustrates another example multi-session testing interfaceaccording to some embodiments described herein.

FIG. 25C illustrates another example multi-session testing interfaceaccording to some embodiments described herein.

FIG. 26 illustrates an example flowchart for providing standard testingsessions and/or express testing sessions according to some embodimentsdescribed herein.

FIG. 27 illustrates an example flowchart for user-proctor matching andassignment according to some embodiments described herein.

FIG. 28 illustrates an example of a swab that includes markings that canbe used by a proctor or an automated system to ensure that testingprocedures are followed.

FIG. 29 illustrates an example flowchart for providing test continuityin the event of network connection problems according to someembodiments described herein.

FIG. 30A illustrates a user taking a remote health or diagnostic testusing a test kit and a user device, such as a mobile phone, according tosome embodiments as described herein.

FIG. 30B illustrates a user scanning a QR code included on a test kitusing a user device, such as a mobile phone, according to someembodiments as described herein.

FIG. 30C illustrates an example of augmented reality (AR) based guidancethat can be displayed on a user device, such as a mobile phone, whereinAR is used to illustrate a location on a test card to which drops shouldbe applied as part of a remote health testing process, according to someembodiments as described herein.

FIG. 30D illustrates another example of augmented reality (AR) basedguidance that can be displayed on a user device, such as a mobile phone,wherein AR is used to illustrate a nose swab procedure as part of aremote health testing process, according to some embodiments asdescribed herein.

FIG. 30E illustrates another example of augmented reality (AR) basedguidance that can be displayed on a user device, such as a mobile phone,wherein AR is used to illustrate further steps in a nose swab procedureas part of a remote health testing process, according to someembodiments as described herein.

FIG. 31 illustrates an example flowchart for training an artificialintelligence (AI) or machine learning (ML) system to interpret testresults according to some embodiments as described herein.

FIG. 32 is a block diagram illustrating an example embodiment of acomputer system configured to run software for implementing one or moreembodiments of the health testing and diagnostics systems, methods, anddevices disclosed herein.

FIG. 33 illustrates another example embodiment of a computer systemconfigured to run software for implementing one or more embodiments ofthe health testing and diagnostics systems, methods, and devicesdisclosed herein.

DETAILED DESCRIPTION

Although certain preferred embodiments and examples are disclosed below,inventive subject matter extends beyond the specifically disclosedembodiments to other alternative embodiments and/or uses and tomodifications and equivalents thereof. Thus, the scope of the claimsappended hereto is not limited by any of the particular embodimentsdescribed below. For example, in any method or process disclosed herein,the acts or operations of the method or process may be performed in anysuitable sequence and are not necessarily limited to any particulardisclosed sequence. Various operations may be described as multiplediscrete operations in turn, in a manner that may be helpful inunderstanding certain embodiments; however, the order of descriptionshould not be construed to imply that these operations are orderdependent. Additionally, the structures, systems, and/or devicesdescribed herein may be embodied as integrated components or as separatecomponents. For purposes of comparing various embodiments, certainaspects and advantages of these embodiments are described. Notnecessarily all such aspects or advantages are achieved by anyparticular embodiment. Thus, for example, various embodiments may becarried out in a manner that achieves or optimizes one advantage orgroup of advantages as taught herein without necessarily achieving otheraspects or advantages as may also be taught or suggested herein.

Certain exemplary embodiments will now be described to provide anoverall understanding of the principles of the structure, function,manufacture, and use of the devices and methods disclosed herein. One ormore examples of these embodiments are illustrated in the accompanyingdrawings. Those skilled in the art will understand that the devices andmethods specifically described herein and illustrated in theaccompanying drawings are non-limiting exemplary embodiments and thatthe scope of the present invention is defined solely by the claims. Thefeatures illustrated or described in connection with one exemplaryembodiment may be combined with the features of other embodiments. Suchmodifications and variations are intended to be included within thescope of the present technology.

Some embodiments herein are directed to a health testing and diagnosticsplatform for facilitating remote health testing via remote connection ofpatients and medical providers. At-home medical testing provides variousbenefits over in-person visits to medical professionals. For example,at-home medical testing provides both safety and convenience to patientsand medical providers. In-person visits by individuals with infectiousdiseases endangers both medical professionals, as well as anyone whoencounters the individuals on their way to the in-person visit. At-hometesting does not involve personal contact between the patient and anyother individuals who may otherwise be at risk. Furthermore, at-hometesting is simply more convenient, as neither medical providers norpatients need to leave the safety or comfort of their home in order toadminister a test using remote testing platforms.

Additionally, because of advancements in medical and logisticstechnology, especially as described herein, at-home testing can now beextremely fast. In some cases, diagnostic tests can be administered andread within seconds. Other tests may require a cure time before beingread or may require delivery to a laboratory to receive results, butresults can still be received within days in most cases.

Applications for at-home medical testing are abundant. For example,at-home testing can be used by travelers in any location to ensure thatthe traveler is healthy before and/or after arriving at a destination,without having to locate medical care in an unfamiliar locale.Furthermore, at-home testing may prevent the spread of infectiousdiseases by providing travelers knowledge of when to quarantine or avoidtraveling altogether, and to avoid bringing home an infectious disease.At-home testing may also be useful for sensitive individuals such as theelderly and children. At-home testing may provide a better experiencefor such sensitive individuals, especially in cases in which the testingprocedure is uncomfortable or invasive. At-home testing can mean thatthe test is done in a safe, comfortable, and familiar environment, sosensitive individuals may feel less stressed and worried during theirtest, allowing testing to proceed more smoothly. In some instances,at-home testing can be performed in a user's home, although this neednot be the case in all instances. For example, as used herein, at-hometesting can refer to testing performed in other locations outside thehome, such as in hotel rooms, airports, or other remote locations whereaccess to an in-person healthcare provider is not available ordesirable. Another consideration for at-home testing is privacy. At-hometesting can be private and discreet, which is ideal for high-profileindividuals or sensitive individuals who want to get tested withoutleaving their homes. Also, accessibility considerations favor at-hometesting. At-home testing is ideal for anyone who has transportationissues or mobility/accessibility considerations.

Considering the advantages of at-home testing, systems and methods forproviding a universal platform for at-home health testing anddiagnostics are provided herein. In particular, a health testing anddiagnostic platform is provided to connect medical providers (such asremotely located medical providers) with patients and to generate aunique, private testing environment. In some embodiments, the testingenvironment may facilitate administration of a medical test to a patientwith the guidance of a proctor. In some embodiments, the proctor maycomprise uncertified personnel, certified medical personnel, and/or aproctor for monitoring an algorithm such as computer software, which mayadminister a medical test. In some embodiments, the computer software isnot administering the medical test but rather is monitoring the medicaltest for abnormalities or deviations or inconsistencies in theadministration or performance or procedure of the medical test that isbeing administered by the uncertified personnel and/or certified medicalpersonnel and/or medical personnel and/or the like. In some embodiments,the patient may be provided with step-by-step instructions for testadministration by the proctor within a testing environment. The platformmay display unique, dynamic testing interfaces to the patient andproctor to ensure proper testing protocols and/or accurate test resultverification.

In some embodiments, the platform may provide mechanisms for userregistration and medical test ordering and fulfillment. In someembodiments, the platform may be connected to one or more pharmacies orthird-party providers that may approve and fulfill test kit orders. Insome embodiments, the platform may provide a testing environmentcomprising a private communication channel (such as over the internet)between a proctor and a patient. In some embodiments, the testingenvironment may comprise one or more unique user interfaces that mayfacilitate seamless testing, submission and verification. In someembodiments, the platform may provide for automatic transmission ofverified test results to users, relevant authorities, and third parties.In some embodiments, the platform may generate a unique health card orpassport, which may provide an easily accessible and understandabletesting summary for a patient and/or third parties.

In some embodiments, the platform may be configured to register, train,and certify medical providers to proctor diagnostic tests using theplatform. In some embodiments, proctors may be enabled to initiatetesting sessions via a virtual waiting room and interpret test resultsusing tools provided by the one or more unique user interfaces of theplatform. In some embodiments, proctors may be enabled to manage morethan one test session concurrently via unique multi-session userinterfaces generated by the platform, which assist with management andadministration of multiple concurrent test sessions.

In some embodiments, the platform may also be configured to provideurgent care to patients in need by collecting symptom and medical datafrom patients and providing such data to relevant medical professionalsand pharmacies. In some embodiments, the platform may facilitatediagnosis of a patient by a third-party medical provider and fulfillmentof a drug prescription by a third-party pharmacy, without any of theparties having direct (e.g., physical or in person) contact.

FIG. 1 illustrates an example flowchart of an at-home testing protocolaccording to some embodiments described herein. In some embodiments, apatient may access the testing platform or a third-party site orapplication in connection with the testing platform. In someembodiments, upon indicating interest in a medical test, apre-qualification survey, questionnaire, or online consultation may betransmitted or initiated at 102, in order to assess patient diseaserisk, eligibility for an at-home test, or other relevant factors, suchas travel history, future travel plans, etc. In some embodiments, theuser may receive the survey via display on a user device at 104. Theuser device may comprise, for example, a personal computer, a cellularphone, a smartphone, a laptop, a tablet computer, an e-reader device, anaudio player, or another device capable of connecting to andcommunicating over a network, whether wired or wireless. In someembodiments, the platform may receive user input of survey answers fromthe user device and attempt to pre-qualify the user based on availableguidelines at 106, such as government stipulated testing requirements.In some embodiments, at 106, information can be gathered about the userthat may facilitate various functionality of the testing platform. Forexample, at 106, the user's identity can be verified. Verification ofthe user's identity can occur in various ways as described furtherbelow. In some embodiments, verification of the user's identitycomprises checking the users ID (e.g., driver's license or passport). Insome embodiments, verification of the user's identity comprises checkingthe user's identity using a health card or test pass as describedfurther below. In some embodiments, the user's identity is verifiedusing biometrics. Additionally, information about the user may begathered at this stage which may facilitate matching the user to aproctor within the system in a manner that improves the efficiency ofthe system. User-proctor matching is described in more detail below. Ifa patient is pre-qualified, user information gathered during userregistration and/or the patient survey may be transmitted by theplatform to a third-party test prescriber at 108. In some embodiments, amedical test may not require a prescription, in which case a test couldbe directly sent to the patient without involvement of a third-party. Insome embodiments, the third-party prescriber could be the administratorof the health testing and diagnostic platform.

In some embodiments, at 110, the platform may receive confirmation of avalid prescription of the requested medical test for the patient. Thetest, along with instructions on how to collect a test sample, may bedelivered, for example, via mail, to the patient by the platformadministrator or by a third-party. In some embodiments, at 112, a userpatient may receive the requested test. Within a prescribed amount oftime (or in some cases, an unspecified amount of time), the user patientmay enter a test environment of the platform via a user device, such asa personal computer, a cellular phone, a smartphone, a laptop, a tabletcomputer, an e-reader device, an audio player, or another device capableof connecting to and communicating over a network, whether wired orwireless at 114. Further, the user device at 114 may be the same userdevice as used at 104 or it may be a different device. For example, theuser may access the pre-qualification survey at 104 on a smart phone andthen, at 114, enter the test environment on the same smart phone or on adifferent device, such as a table or laptop. Upon entering the testingenvironment or a virtual waiting room of the test environment, theplatform may manually or automatically match the user patient with amedical provider proctor at 116 to administer the test. The system mayprovide user-proctor matching in a variety of ways to improve theefficiency and accuracy of the platform. As noted below, various factorsof both the users and the proctors may be analyzed to facilitateuser-proctor matching.

Upon matching of the user and the proctor, a testing session may beginat 120, with a prompt and testing session being provided to the proctorand a test session recording beginning at 122. In some embodiments,during the testing session, the proctor may guide the user patientthrough the testing process using provided prompts and tools in order toreceive a test result at 124. The proctor and/or the platform mayperform validation of the test result using a video feed of the testfrom the user device or through a static image taken by the user deviceat 126. In some embodiments, the platform may store the test result inconnection with a user profile created for the patient at 128.Furthermore, at 128, the test results may be reported to variousgovernment agencies, health authorities, and/or third parties asmandated or desired. In some embodiments, the platform may generate andtransmit the verified test result to the patient at 130. In someembodiments, the verified test results may be in the form of a digitalhealth card or “passport” with various information including the testresult, date of the test, expiration, and any other relevant details. Insome embodiments, the verified test result may be received by thepatient via the platform or a third-party website or application at 132.

FIG. 2 illustrates an example flowchart of a method for registering auser and ordering a diagnostic test for an at home-testing protocolaccording to some embodiments described herein. In some embodiments, auser patient may access the platform and be prompted to register withthe platform and create a user account at 202. In some embodiments,registration may involve collection of user data, such as personalinformation, medical history, and/or insurance information, amongothers. In some embodiments, registration and/or creation of a useraccount may result in a user profile creation within a user database ofthe platform, in which the above information may be stored at 204. Insome embodiments, user identity information is verified and stored at204. In some embodiments, information that will be used to facilitateuser-proctor matching can be obtained and stored at 204.

Also, upon creation of a user account, the user may order a test kit at206, which may involve a pre-qualification process such as thatdescribed with respect to FIG. 1. In some embodiments, the platform mayprocess the test order, including payment and/or insurance at 208. Uponcompletion of the transaction process, the platform may automaticallyorder a test kit, such as through an application programming interface,from a third-party pharmacy at 210. In some embodiments, the pharmacymay review the user information and request at 212 and approve a testkit order at 214. In some embodiments, after approval, a test kit may beshipped to the patient from the pharmacy, from the testing platform, orfrom a third party at 216. In some embodiments, the patient may receivethe test kit at 218 and be prompted to activate the test kit at 220.Activation of the test may involve connecting test identificationinformation with the user profile, in order to ensure that the patientis using the correct test at the time of the testing session. In someembodiments, the health testing and diagnostic platform may update theuser profile of the patient with the unique test kit information at 222.

In some embodiments, one or more of the exchanges between the user andthe testing platform as described above with reference to one or both ofFIGS. 1 and 2 may be made through and/or facilitated by an inline frameor “iFrame” HTML element of a website or web application. In at leastsome of these embodiments, the website or web application may be hostedby an entity other than that which maintains the testing platform, suchas a pharmacy or e-commerce business. Such an iFrame may effectivelyenable a website, web application, or components thereof that are hostedby the entity that maintains the testing platform to be embedded in thewebsite or web application that is hosted by this other entity. In thisway, users of the website or web application hosted by another entity,e.g., a pharmacy or e-commerce business, can quickly and seamlesslyconnect with the testing platform to order test kits, among otherthings. In some cases, test kit orders and/or prescription drug ordersmay be fulfilled at least in part by the other entity. For instance, ifthe other entity is a pharmacy, then test kit orders and/or prescriptiondrug orders may be made available to users for pickup at their nearestpharmacy branch. Similarly, if the other entity is an e-commercebusiness, then test kit orders and/or prescription drug orders may bedelivered to users by leveraging the business's existing supply chainand logistics infrastructure. In some embodiments, users may have theoption to have test kit orders and/or prescription drug orders deliveredto them via a shipping service or a courier service for rapid same daydelivery.

As an example, the website for “Duncan's Pharmacy” may include an iFrameelement that enables users of the website to interface with the entitythat maintains the testing platform without having to manually navigateaway from and/or back to the Duncan's Pharmacy website. As such, usersof the website for Duncan's Pharmacy may be able to easily completepre-qualification surveys, create accounts with the testing platform,order test kits, and the like. When ordering test kits through theiFrame on the Duncan's Pharmacy website, in some instances, users may begiven the option to have the test kits delivered directly to them orpick their test kits up from their nearest location of Duncan'sPharmacy. Other arrangements are possible.

FIG. 3 illustrates an example flowchart of an on-demand testing protocolwith a proctor according to some embodiments described herein. In someembodiments, once a test kit has been received and activated by apatient, the patient may access the platform via a user device in orderto initiate an on-demand testing session at 302. In some embodiments,the on-demand testing session must be initiated by the patient within aprescribed period of time after receiving or activating the test kit. Insome embodiments, initiation of the testing session by the patient maycause the platform to place the patient in a virtual waiting room, wherethe patient's testing session will be queued at 306 pending a match withan available medical provider proctor at 308 In some embodiments, afterthe proctor has been matched with the patient or upon manual selectionof the patient by the proctor, the proctor may review the patientinformation and accept the request to begin the testing session at 310.Acceptance of the request may initiate a unique, one-way or two-wayvideo session between the patient and the proctor at 312 provided by theplatform. In some embodiments, the video session may involve a guidedtest process at 314 for the patient on a user device and at 316 for theproctor using a proctor device, which could be a mobile device, laptop,desktop, or other computer device. As a first step in the testingsession, the proctor and patient may follow provided on-screen steps toensure that the patient is verified and qualified at 318, 320, as wellas to verify the that the test to be used matches the test informationstored in the user profile upon test activation. After verification andqualification, the proctor may guide the patient through a series ofsteps comprising a testing protocol in order to achieve a test result.In some embodiments, a test result may be verified by the proctor and/orpatient at 322, 324. In some instances, test result verificationinvolves a visual inspection of the test kit by the proctor to determineand manually submit the test result. In some embodiments, the verifiedtest result is submitted by the proctor and stored within a testdatabase of the platform at 326.

FIG. 4 illustrates an example flowchart of a method of reporting testingresults according to some embodiments described herein. In someembodiments, a verified test result may be received by the testingplatform at 402 from a testing session completed by a patient andproctor. In some embodiments, the platform may update the user profilewith the verified test results at 404. In some embodiments, at 406, theplatform may transmit the verified test results to various third-partyentities, including national, state, and/or local government entitiesand third-party entities at 408, and to the user at 410. In someembodiments, transmission of the verified test result to the user may bethrough a third-party. In some embodiments, the verified test resultsmay be transmitted in the form of a health card or passport, withadditional information regarding the test, including the test type, dateof the test, test determination or result, or any other relevantinformation. In some embodiments, in the event of a positive test, theuser patient may be referred to a telehealth consultant via the platformor by a third-party at 412.

FIG. 5 illustrates an example diagram of a health card or test passaccording to some embodiments described herein. In some embodiments, asnoted above, verified test results may be transmitted to a user patientin the form of a health card, test pass, or health passport. Such ahealth card may provide an easily accessible summary of test results toa patient and to interested third parties such as government officials,travel authorities, or event organizers/security. In some embodiments,the health card 500 may comprise personal information 502, identifyingthe user patient by the patient's name, date of birth, photograph, orotherwise. In some embodiments, the health card may also comprise a testresult 504, a date of issue of the test result 506, and a test type 508.In addition, the health card may comprise an expiration 512, which maycomprise easily accessible information regarding expiration of thedependability of the test result based on health guidelines provided bygovernment entities or otherwise. In some embodiments, the health card500 may comprise a quick response (QR) code that may direct interestedparties to a webpage containing additional information about thepatient, the test, the test results, and/or other tests that the patienthas undergone. Additional detail regarding test passes is describedfurther below.

FIG. 6 illustrates an example flowchart for a proctor certification andtesting protocol according to some embodiments provided herein. In someembodiments, a medical provider may apply and register to become aproctor for the health testing and diagnostic platform through, forexample, a website or mobile application at 602. In some embodiments,the proctor may undergo a training process at 604 in order to preparethe medical provider to manage patient testing sessions and administerat-home medical testing via the platform. Upon passing one or morecertification and verification tests, the proctor may be certified bythe platform automatically or upon manual approval of an administratorat 606. In some embodiments, once certified, a proctor may gain accessto a proctor dashboard at 608, wherein the proctor dashboard may be usedto track testing statistics, proctor performance, and initiate testsessions. In some embodiments, initiating a testing session via thedashboard may enter the proctor into a virtual waiting room at 610,where the proctor may select a patient (or patients) for a testingsession or be automatically assigned to a patient (or patients). In someembodiments, after verifying patient information, the proctor may entera test session with the patient(s) at 612. In some embodiments, uponcompletion of prompts (e.g., step-by-step prompts) comprising the testsession protocol, a test result may be obtained, which can beinterpreted and submitted by the proctor at 614.

FIG. 7 illustrates an example flowchart for providing care to a patientvia a health testing and diagnostic platform according to someembodiments provided herein. In some embodiments, in addition toproviding a remote medical test environment, the platform may be used toprovide general, urgent, or emergency care to a patient throughconnection of patients to third-party medical providers. In someembodiments, a user patient may enter a website or app of the platformat 702. In some embodiments, the user patient may be prompted to answera series of questions generated by the platform in order to verifysymptoms of and/or other information about the user patient at 704. Inaddition to the symptom checker, the user patient may also be promptedby the platform to complete a medical questionnaire to provideadditional information regarding the patient's condition, healthhistory, and/or other relevant information at 706. In some embodiments,the information gathered at 704 and 706 can include informationregarding the user patient's travel history and/or future travel plans.For example, the process of can include presenting the user withquestions regarding their travel plans (e.g., “Are you planning totravel into or out of the United States within the next 72 hours?”). Theinformation from the symptom checker and the medical questionnaire maybe transmitted automatically at 708 to a third-party or registeredhealthcare provider. The information may be routed to specific medicalproviders based on the answers provided by the patient such that medicalproviders with specific expertise, language skills, and/or location maybe selected. In some embodiments, the medical provider may provide adiagnosis to the patient, at 708 which may include one or more drug ortest prescriptions at 710 to be fulfilled at 714 via a third-partypharmacy. All of the above steps can be completed by the platformwithout the patient being physically present with the medical provideror at the pharmacy. In some embodiments, the patient may be prompted toprovide delivery information to the platform at 712, which may beautomatically transmitted to the pharmacy for fulfillment of theprescription.

As mentioned above, in some embodiments, one or more of the exchangesbetween the user and the testing platform as described above withreference to one or both of FIGS. 1 and 2 may be made through and/orfacilitated by an iFrame of a website or web application. Similarly, insome embodiments, the user may enter the website or app of the platformat 702 in FIG. 7 through an iFrame element provided on a website or webapplication that is hosted by an entity other than that which maintainsthe platform, such as a pharmacy or e-commerce business. As such, inthese embodiments, one or more of the exchanges between the user and theplatform at one or more of 704, 706, and 712 may occur by way of theiFrame.

FIG. 8 illustrates an example pre-testing confirmation interfaceaccording to some embodiments. The pre-testing confirmation interfacemay be displayed to a patient who has indicated that the patient isready to begin testing. In some embodiments, the pre-testingconfirmation interface may comprise various verification questions thatare designed to ensure that the patient has the time and materialsnecessary to being a testing session. For example, it may be requiredthat the patient has at least 20 minutes to administer the test, as wellan unopened test package received via mail or otherwise properlyobtained. Within the pre-testing confirmation page, the patient may alsoneed to verify personal information, such as their date of birth, inorder to proceed to the virtual waiting room and to a testing session.

FIG. 9 illustrates an example pre-testing virtual waiting room accordingto some embodiments provided herein. In some embodiments, thepre-testing virtual waiting room may be displayed to a patient aftercompleting pre-testing verification and confirmation. In the virtualwaiting room, the patient may await dynamic connection with a proctor,who will oversee a testing session with the patient. In someembodiments, once a proctor has selected to begin a test with thepatient or is automatically assigned to the patient, a unique activationcode may be transmitted to the patient via short message service (SMS),text message, electronic mail (E-mail), voice call, or anotherelectronic communication channel.

FIG. 10 illustrates an example unique code submission interfaceaccording to some embodiments provided herein. In some embodiments, apatient may be directed to the unique code submission interface once thepatient has been matched with a proctor. In some embodiments, the matchmay occur after the patient enters a virtual waiting room. In someembodiments, the unique code submission interface may allow the patientto enter a unique activation code for entering a private one-way ortwo-way communication channel with a proctor. In some embodiments, theunique code submission may initiate testing session between the patientand the proctor.

FIG. 11 illustrates an example patient testing interface according tosome embodiments provided herein. The example testing interface 1100 maybe displayed to a patient for facilitating one or more medical tests onthe patient and provides instructions and tools for self-administeringthe test and connecting with a proctor, who oversees and providesguidance during the test. The interface may be designed to accuratelyrecord a patient test result and to allow the patient to understand theexact step-by-step procedure that must be followed to achieve asuccessful test result.

In some embodiments, the example testing interface 1100 may comprise asession progress indicator 1102. The session progress indicator 1102 mayprovide a visual and/or audible indicator of the progress of a testingsession. For example, the session progress indicator 1102 may show astep number, a timer, a timeline, or other indicator of progress. Thesession progress indicator 1102 may assist a patient in determining thecurrent status of the testing session.

In some embodiments, the example testing interface 1100 may comprisetesting instructions 1104. In some embodiments, the testing instructions1104 may comprise step-by-step instructions that the patient must followin relation to a provided at-home test kit in order to self-administerthe test and achieve a valid test result. In some embodiments, thetesting instructions 1104 may be read by a patient in addition toaudible instructions provided by the platform or manually by a proctor.The proctor may be heard by the patient via a secure communicationchannel and in some embodiments, may be visible in a live proctor videofeed 1108. In other embodiments, a virtual proctor avatar may be showninstead of the proctor video feed. In some embodiments, a prerecordedvideo may be displayed rather than a live proctor video feed.

In some embodiments, proctor information 1108 may be displayed andprovide information to the patient regarding the proctor that isoverseeing the testing session, including, for example, the proctor'sname, certifications, and a photograph of the proctor, among others.

In some embodiments, the example testing interface 1100 may alsocomprise one or more options 1110, a support link 1112, and one or morecall options 1114. In some embodiments, the options 1110 may comprisegeneral platform options, including accessibility options, videooptions, and other miscellaneous options. In some embodiments, thesupport link 1112 may connect the patient to an administrator or othersupport personnel, in the event that such support is needed. Forexample, if there is an emergency with the proctor or patient, or thereis an issue with testing, the support link 1112 may allow a third-partyto join the testing session. The call options 1118 may, for exampleallow a patient to mute their device microphone or end the testingsession.

FIG. 12 illustrates another example patient testing interface accordingto some embodiments described herein. In some embodiments, the patienttesting interface may comprise directions to register a medical testusing a camera on the user device. For example, some commerciallyavailable diagnostic tests comprise a QR code comprising a data matrixthat has an encoded ID. In some embodiments, the platform may perform ascan through the user camera to read the data matrix. In someembodiments, the read data may be sent automatically to the testprovider through, for example, an application programming interface. Insome embodiments, the delivery and patient data and all other pertinentinformation may be retrieved from the test provider to verify that thetest and patient in the testing session match with the platform records.In some embodiments, the user may be directed to display or scan thecode multiple times throughout a testing session in order to verify thatthe same test is being used throughout an entire session. For example,scanning the code at the start of the testing session, immediatelybefore and after critical testing steps, and/or at the end of thetesting session can prevent a user from switching tests midway throughthe testing session. In some embodiments, the data matrix can also beread, such that a unique code is obtained, which can be compared againstall previous codes read by the platform. If a duplicate code is read,the test may be discarded.

FIG. 13 illustrates an example test initiation interface according tosome embodiments herein. In some embodiments, the test initiationinterface comprises a test initiation mechanism and an indicator of thenumber of patients waiting in a virtual waiting room. Upon, selection ofthe test initiation mechanism, a test session may begin between aproctor and a patient. In some embodiments, a proctor may be prompted toselect a patient from a list of patients in the virtual waiting room. Insome embodiments, the proctor may be automatically and dynamicallyassigned to a patient in the waiting room. In some embodiments, theassignment may be based on proctor location, language ability, medicalexpertise, or other factors. In other embodiments, the assignment may bemade based on wait time of patients.

FIG. 14 illustrates an example pre-testing interface according to someembodiments herein. In some embodiments, the pre-testing interface ofFIG. 14 may be displayed to a proctor upon initiating a test session.The pre-testing interface may comprise patient information, such as thepatient's name and date of birth, as well as a photo of the patient. Insome embodiments, the proctor may be prompted to verify that the patientthat joins the testing session matches the patient shown in the patientphoto of the pre-testing interface. In some embodiments, the pre-testinginterface may comprise one or more audio/video options, such as optionsfor selecting a microphone and speaker for conducting the testingsession.

FIG. 15A illustrates an example testing interface 1500 according to someembodiments herein. In some embodiments, the example testing interface1500 may be displayed to a proctor for testing one or more patients andprovides tools to facilitate management of testing, including verbalprompts, a video feed of the patent, and a timer and alert mechanism forthe test read. The interface may be designed to accurately record apatient test result and to allow the proctor to provide usefulinformation about various issues that may have resulted in a failedresult or no result being obtained.

In some embodiments, the example testing interface 1500 may comprise asession progress indicator 1502. The session progress indicator 1502 mayprovide a visual and/or audible indicator of the progress of a testingsession. For example, the session progress indicator 1502 may show astep number, a timer, a timeline, or other indicator of progress. Thesession progress indicator 1502 may assist a proctor in determining thecurrent status of the testing session, especially in situations in whichthe proctor is managing multiple testing sessions simultaneously.

In some embodiments, the example testing interface 1500 may comprisepatient information 1504 and a patient video feed 1506. The patientinformation 1504 may provide information to the proctor regarding thepatient that is the subject of a testing session, including, forexample, the patient's name, date of birth, age, language, and aphotograph of the patient, among other types of information. In someembodiments, the patient video feed 1506 may comprise a live video feedof the patient during the testing session. In some embodiments, thepatient video feed may comprise a recording of the patient. In someembodiments, the patient video feed 1506 may allow a proctor to monitora patient and testing session, and to direct the patient regarding thetest protocol.

In some embodiments, the example testing interface 1500 may alsocomprise a prompt/script 1508, a notes/test result section 1510, and apatient view 1512. In some embodiments, the prompt 1508 may comprise awritten script for the proctor to audibly read to the patient during thetesting session. In some embodiments, the prompt 1508 may automaticallyupdate based on the current step of the testing session. In someembodiments, a navigation menu 1520 may be sued by the proctor to moveforward and back through the testing steps. In some embodiments, thenotes/test result section 1510 may comprise various notes for theproctor's consideration during the current testing step. Duringinterpretation of a test, the notes/test result section 1510 maycomprise a guide for test interpretation and/or a mechanism to submit atest result. In some embodiments, the patient view 1512 may comprise asection showing the content that is currently being displayed on apatient's computer. In some embodiments, the patient view 1512 maycomprise a copy of the content displayed on the patient's screen or alive stream of the patient's screen.

In some embodiments, a prompt 1508 may comprise a written script on theinterface, which will indicate, for each step of or whatever phase oftesting the particular patient is in, the words that the proctor willread for that specific step. In some embodiments, the prompt may beautomatically read by the health testing and diagnostic platform. Inother embodiments, the proctor may read the prompt audibly to thepatient. In some embodiments, a prerecorded video or dialogue may beplayed at specific times during the testing, which will comprise aprerecorded script comprising the prompt 1508. In some embodiments, theprerecorded script may be played under supervision of a proctor.

In some embodiments, the example testing interface 1500 may alsocomprise one or more options 1514, a support link 1516, and one or morecall options 1518. In some embodiments, the options 1514 may comprisegeneral platform options, including accessibility options, videooptions, and other miscellaneous options. In some embodiments, thesupport link 1516 may connect the proctor to an administrator or othersupport personnel, in the event that such support is needed. Forexample, if there is an emergency with the proctor or patient, or thereis an issue with testing, the support link 1516 may allow a third-partyto join the testing session. In some embodiments, a substitute proctormay be able to join the testing session to resume testing using, forexample, the session progress indicator 1502 and the prompt 1508.

In some embodiments, the health testing and diagnostic platform mayassign one or more designated users (e.g., supervisors or others) tohave administrator rights and privileges. In some embodiments, anadministrator may view the full scope of proctor sessions occurring,including a list of proctors active on the platform and pending testsessions. In some embodiments, an administrator can join into a testingsession anonymously and quietly as a third-party overseer, for purposessuch as random audits. In some embodiments, administrators may jointesting session for joint proctor training or feedback. In someembodiments, in an emergency situation, the support link 1516 mayconnect the proctor to a customer service team, wherein the customerservice team may be sent part of or the whole dataset of a testingsession, including the user information, the user picture, and proctorinformation.

FIG. 15B illustrates another example testing interface according to someembodiments provided herein. In some embodiments, the testing interfacemay comprise a video feed 1506 comprising an image/video of the patient1522 or a plurality of images/videos of a plurality of patients. In someembodiments, software, such as machine learning or artificialintelligence software, or non-machine learning or artificialintelligence algorithms (for example, image segmentation analysis,pattern recognition, or the like) or otherwise, may be used to detectelements within the video feed 1506. These elements may include, forexample, a patient 1522, a patient reference element 1524, a test 1526,and a test reference element 1528. In some embodiments, the software maybe configured to monitor the video feed 1506 to ensure proper testprotocol and completion. For example, in some embodiments, the softwaremay utilize image or video recognition algorithms to periodically orcontinuously measure one or more relative distances and/or movements ofthe patient reference element 1524 and the test reference element 1528.In some embodiments, the patient reference element 1524 may comprise thepatient's nostril, nose, lip, mouth, eye, ear, or any other body part.In some embodiments, the testing reference element 1528 may comprise aline or other visual indicator on the test 1526. In some embodiments, bymeasuring a horizontal and/or vertical distance and/or movement betweenthe patient reference element 1524 and the test reference element 1528,the software may compare such values against predetermined thresholdvalues to verify proper testing protocols are satisfied, for example,minimum/maximum distance traveled or reached, minimum/maximum number ofmotions and/or rotations performed. In other embodiments, machinelearning and/or artificial intelligence may be used to interpret thepatient video feed 1506 to verify testing procedures are completedproperly.

FIG. 16 illustrates an example test analysis and interpretationinterface according to some embodiments herein. In some embodiments,during a test or upon completion of a test by a patient, the test may bedisplayed on a camera of a user device, such that the test and resultcan be verified. In some embodiments, the test may be verified manuallyby a proctor viewing the image of the test displayed via the testanalysis and interpretation test analysis and interpretation interface.In some embodiments, the health testing and diagnostics platform mayrecord the patient video to verify test integrity.

In some embodiments, the test analysis and interpretation interface maycomprise one or more interactive tools, which the proctor may utilize toensure test integrity. For example, one tool that may be used would bean interactive pen/marker/highlighter that can be used to annotate thepatient video feed to guarantee that the test is not moved or altered.

FIG. 17 illustrates another example test analysis and interpretationinterface according to some embodiments herein. FIG. 17 illustrates apatient video feed showing a completed test awaiting interpretation.Within the test analysis and interpretation interface, a proctor mayview a patient test image/video, interpret a test results, and selectthe interpreted test results for submission.

In some embodiments, a patient video feed or test image is not optimalsuch that the result may be difficult to interpret. For example, thepatient's video may be too bright or dark, may be blurry, or otherwiselack sufficient visibility. Thus, in some embodiments, the test analysisand interpretation interface may comprise one or more image adjustmenttools to manipulate image properties such as the contrast andbrightness. The image adjustment tools may be used to adjust the imageto enrich the view of the test. Example image adjustment tools include,for example, brightness, contrast, saturation, and color adjusters,among others.

In some embodiments, instead of utilizing live video of a patient test,the health testing and diagnostic platform may capture one or morestatic images of a patient test from the live video feed. In someembodiments, the static image may be captured directly from the userdevice of the patient. In some embodiments, the test image can be sentas a full-size file over the internet to the proctor and viewed on thetest analysis and interpretation interface. In some embodiments, theimage can be adjusted using the one or more image adjustment tools. Insome embodiments, using an image captured using the user device mayresult in an image that has enhanced resolution and clarity relative tousing a live image streamed over a video conferencing network. In someembodiments, the image of the test obtained from the user device of apatient may be captured during a patient video session with the proctor,but is not captured from the live video stream.

FIG. 18 illustrates another example testing interface according to someembodiments herein. The testing interface of FIG. 18 illustrates theconclusion of a testing session from the proctor perspective. Thetesting interface comprises a mechanism for ending the testing sessionand severing the audio/video channel with the test patient.

FIG. 19 illustrates an example testing summary interface according tosome embodiments provided herein. In some embodiments, the testingsummary interface may be used by an administrator, proctor, or healthofficial to analyze testing statistics and distribution across one ormore test sites or demographics. For example, the testing summaryinterface may comprise data including remaining available tests,approved test sites, a number of administered tests, a number of tests,and a distribution of administered tests and proctors across test sites.From the testing summary interface, a user may access a testdistribution interface, as described with respect to FIG. 20.

FIG. 20 illustrates an example test distribution interface according tosome embodiments provided herein. In some embodiments, the testdistribution interface may be used by an administrator, proctor, orhealth official to distribute available tests among one or more testsites to be administered with or without the health testing anddiagnostic platform remote testing protocol. Submission of a testdistribution may automatically initiate an order and/or distribution ofthe submitted tests to the selected test sites.

FIG. 21 illustrates an example multi-session management interfaceaccording to some embodiments provided herein. The multi-sessionmanagement interface displays one or more pending test sessions, as wellas their statuses. The sessions displayed in the multi-sessionmanagement interface may comprise sessions of patients in a virtualwaiting room or currently in a test session. As such, proctors, via themulti-session management interface, may manage pending test sessions andinitiate new test sessions as patients and the proctor become availablefor testing. In some embodiments, the multi-session management interfacemay be general in that it shows test-ready patients for any test,location, or other parameter. However, in some embodiments,multi-session management interface may be specific to a specific medicaltest, a specific location, or to patients who speak a certain language,among others.

FIG. 22 illustrates an example testing dashboard interface according tosome embodiments provided herein. In some embodiments, the testingdashboard interface displays a list of completed test sessions,including test results and other test details such as the date of testcompletion. In some embodiments, the testing dashboard interface mayalso comprise one or more test statistics, summarizing the test data foreach specific proctor, test type, or test location, among other types ofinformation. For example, the testing dashboard interface may comprisestatistics regarding the remaining tests, the completed tests, testresult data for a specific time, location, or demographic and overalltest result data.

FIG. 23 illustrates an example multi-session testing interface accordingto some embodiments provided herein. In some embodiments, themulti-session interfaces shown herein may be designed to manage ascenario where a proctor is managing more than one testing sessionssimultaneously. In some embodiments, the multi-session interfaces maycomprise multiple views that can be displayed, each view representing aone-to-one with a patient. As such, in some embodiments, the proctor isable to interface with a single patient at a point in time, but managemore than one patient testing sessions simultaneously, and switchbetween those sessions seamlessly. In some embodiments, themulti-session interfaces described herein may facilitate isolatedaudio/video sessions between multiple patients simultaneously throughuse of single-channel audio, on-screen session progress indicators, andproctor prompts.

In some embodiments, the multi-session testing interfaces describedherein may allow for concurrency of about 2 to about 20 patient testingsessions for a single proctor. In some embodiments, the multi-sessiontesting interfaces may comprise a workflow timeline that identifiespatient testing progress for pending testing sessions, such that aproctor can immediately understand the progress of each pending sessionand switch between each isolated session as needed. For example, forsome disease testing, there may be a testing cure time during which thepatient and proctor are waiting for the test results. During this time,the multi-session testing interface may allow a proctor to switch anactive session to another patient at a different point in the testingprocess such that multiple sessions can be managed simultaneously. Themulti-session interfaces may introduce a supply line of isolated patientvideo sessions such that the patient sessions are stacked efficientlyand proctor availability is maximized. In some embodiments, themulti-session interfaces may comprise a management tool that allowsproctors to track the concurrent session timeline and to understand theupcoming timing requirements of each isolated session and the sessionscollectively.

In some embodiments, each patient testing session enables a separateaudio/video channel such that patients are isolated from each other andcannot hear or see other patient testing sessions, while the proctor mayactivate each individual patent testing session to communicate directlywith each patient. Thus, the audio/video channels for each patient aresegmented into separate feeds such that individual sessions aredistinctly managed separately with separate session IDs and in such away that none of the patients can talk to each other or are even awarethat multiple sessions are occurring concurrently. In some embodiments,a proctor may activate a specific patient testing session through anactivation mechanism on the proctor's screen, such as by selecting apatient video feed. The activation mechanism will open the audio and/orvideo channel with the specific patient for which the patient testingsession has been chosen. This configuration minimizes the risk ofexposing sensitive medical or personal data between patients; only theproctor may communicate with each patient. Furthermore, themulti-session interfaces described and shown herein facilitate efficientsession switching through visual prompts that allow a proctor tounderstand the point at which each testing session is currentlyprogressed.

In some embodiments, the multi-session interfaces may compriseindividual patient mute mechanisms, which may close the communicationchannel with an individual testing session, as well as a global mutemechanism, which may close all communication channels between theproctor and all pending testing sessions. In some embodiments, only onepatient testing communication channel may be opened at a time, such thata proctor may only communicate with a single patient at a single pointin time. For example, opening a communication with one patient mayautomatically close (e.g., mute) a communication channel with all otherpatients to ensure that privacy between patients is maintained.

The multi-session interface of FIG. 23 illustrates a proctor view inwhich the screen is separated into a main session (e.g., the upperportion of the screen) and one or more secondary sessions (e.g., shownin a lower toolbar of the screen below the main session). In someembodiments, the proctor may have an open communication channel to themain session, while the secondary sessions remain muted. In someembodiments, the proctor may be enabled to exchange the main sessionwith one of the secondary sessions by selecting one of the secondarysessions. Selecting one of the secondary sessions may cause display ofthat secondary session as the main session, and relegate the previousmain session to the secondary session toolbar. In some embodiments, themulti-session interfaces may comprise one or more visual cues toindicate to the proctor the status of each patient session and to alertthe proctor if attention is needed for any given session. For example,in the illustrated embodiment, such visual cues include an elapsedtesting time for each patient, a countdown timer, and a questionindicator.

FIG. 24 illustrates another example multi-session testing interfaceaccording to some embodiments provided herein. In some embodiments, amulti-session testing interface may comprise a multi-window interface,as shown in FIG. 24. In some embodiments, the multi-window interface maycomprise one or more testing interfaces, such as that shown in FIG. 15A.However, in some embodiments, the multi-session testing interface may beenabled to track and manage multiple testing interfaces concurrently. Aswith the multi-session testing interface of FIG. 23, the interface maybe segmented into separate feeds such that individual sessions aredistinctly managed separately with separate session IDs and in such away that none of the patients can talk to each other or are even awarethat multiple sessions are occurring concurrently. For example,selecting one window of the one or more windows may open a securecommunication channel with the patient of the selected window, andclosing any other open communication channels. Also, each window maycomprise one or more visual or auditory indicators of test status, suchthat a proctor can more easily manage the one or more patient testsessions occurring concurrently. In some embodiments, the multi-sessiontesting interface may comprise individual testing sessions, each openedin a separate browser window.

FIG. 25A illustrates another example multi-session testing interfaceaccording to some embodiments provided herein. The multi-session testinginterface of FIG. 25A may be functionally similar or identical to theinterface of FIG. 24, except that the individual testing sessions may bedisplayed in a single browser window.

FIG. 25B illustrates another example multi-session testing interface2502 according to some embodiments. In some embodiments, the testinginterface 2502 may comprise one or more patient video feeds 2504. Insome embodiments, the patient video feeds 2504 may comprise individualconcurrent testing sessions with individual patients. In someembodiments, the individual testing sessions may be automaticallyhighlighted or manually selected by a proctor in order to interact withthe patient subject of the highlighted session. In some embodiments, thehighlighted session may also pop-out or otherwise enlarge relative tothe other sessions, such that the proctor may access relevantinformation. In some embodiments, a proctor may use the interface 2502to monitor a computer algorithm, which may be autonomously administeringthe tests to patients in patient video feeds 2504. In some embodiments,individual sessions may be highlighted by the algorithm for proctorintervention into the testing session. In some embodiments, the proctormay manually intervene in one or more testing sessions by selecting thedesired patient video feed 2504.

FIG. 25C illustrates another example multi-session testing interfaceaccording to some embodiments herein. In some embodiments, the interfacemay comprise a timeline comprising one or more steps or stages S_(n),wherein n is an integer representing the stage number in a sequence ofstages comprising the test protocol. For example, the interface of FIG.25C comprises S1, S2, and S3 representing three stages of a testingprotocol. In some embodiments, the interface may comprise one or morepatient video feeds 2504. The patient video feeds may be located withinthe interface in such a way as to indicate the testing stage at whichthe patient is currently undergoing. For example, in the illustratedembodiments, patient 1 (P1) is at stage 1 (S1), patient 2 (P2) is atstage 2 (S2), and patient 3 (P3) is at stage 3 (S3). In someembodiments, the testing interface may be utilized to allow a proctor tomonitor one or more concurrent testing sessions. The testing interfacemay allow the proctor to easily understand the stage at which eachtesting session is currently undergoing. In some embodiments, thepatient video feeds 2504 may change location upon completion of eachtesting stage, such that the interface is automatically and dynamicallyupdated.

Expedited or Express Proctoring Platforms for at-Home Testing

The platforms and systems described throughout this application canprovide a number of advantages relating to the administration andproctoring of at-home health testing and diagnostics. For one, suchplatforms and systems provide users with the option to perform healthtesting and diagnostics from the comfort of their own home or otherwisewithout having to travel to visit a healthcare professional in person.This in itself can provide a number of benefits including, saving time,increasing availability of testing, and decreasing the risk of exposureto and/or spread of an infection disease, among others.

An additional benefit that can be achieved using the platforms andsystems described herein is that these can be optimized to provide for ahigh throughput of user tests, while at the same time minimizing theresources required to run the platform. For example, as described above,the platforms and systems described herein can be configured to allow asingle proctor to proctor a plurality of user tests at once. This canprovide advantages both for the platform and for the users. For example,the platform can facilitate testing using fewer proctors, thus leadingto a reduction in operating costs. At the same time, the testing anddiagnostics provided through the system and platforms described hereincan still be readily available to a large number of users and wait timesfor entering a proctored test session can be reduced. Additionaladvantages achieved by some embodiments described herein may includereduction in costs associated with operating a testing platform (e.g.,through a reduction in operating and/or oversight costs) and/orreduction in patient costs (e.g., by having them avoid unnecessarytravel costs). Additionally, some embodiments may allow users tomulti-task while testing, thereby increasing flexibility for the users.

These and other benefits of the platforms and systems describedthroughout this application can be further achieved or even improved by,in some instances, offering certain users a more streamlined or expresstest session. As will be described in more detail below, such expresstest sessions can, for example, require less proctor involvement and/ordecrease the duration of the test session for the user when comparedwith standard (e.g., non-express) test sessions. This can, in someinstances, further increase the benefits and advantages associated withthe systems and platforms for proctoring at-home health testing anddiagnostics by further improving the user experience (e.g., bydecreasing test session duration) and/or maximizing the availability andreach of the platform (e.g., by increasing the platform's ability toprovide a high number of test sessions using fewer proctors).

Accordingly, in some instances, the platform can be configured to tailora proctoring session to a user's level of test-taking experience. Forexample, users with less experience with the test and/or platform can bedirected into a standard proctoring session, while users with moreexperience with the test and/or platform can be directed into an expressproctoring session. As an even more specific example, users who areusing the platform to take a test for the very first time (“first-timeusers”) may be directed to the standard proctoring session (where, forexample, a proctor provides full-fledged step-by-step instructions fortaking the test), while users who have previously used the platform totake tests (“repeat users”) may be given the option to eitherparticipate in (i) the standard proctoring experience, or (ii) anexpress or expedited proctoring session where the users take the testwith reduced proctor participation/intervention.

As will be described in more detail below, various factors can beconsidered by the system in determining whether to offer or provide auser an express testing session. In some embodiments, the factors usedby the systems disclosed herein to determine eligibility for expresstesting session can include one or more of the following: a test taker'spast experience in taking such a test, a test taker's age, a testtaker's language skills, a test taker's ability to follow instructions(for example, whether a system detects that the patient has completedcertain initial tasks of the test within a certain period of time and/orcompleted certain initial tasks competently and/or with minimalsupervision and/or within a minimum number of attempts, and in someembodiments, one or more of the foregoing factors can be used by thesystem to enable the system to provide real-time or substantiallyreal-time grading of a user to determine eligibility of the user to takeand/or be offered an express testing session), a test taker's computerliteracy skills, a test taker's internet connection speed and/orconnection quality/stability, a test taker's ability to have aphysically present third-party to observe the test taker, an artificialintelligence algorithm used to observe the test taker's skills and/orability to follow instructions and/or administering the test (forexample, the use of artificial intelligence algorithms to determinewhether the test taker has inserted a swab to a minimum instructed depthinto a nasal cavity (or other orifice), and/or whether a test taker hascompleted a minimum number of rotations of the swab in the nasal cavity(or other orifice), or the like). In some embodiments, a factor indetermining a test taker's eligibility for taking an express testingsession can include but is not limited to whether the test taker haspaid a necessary fee, and/or the number of other patients in a queuewaiting to take a test, and/or the number of available proctorsadministering tests, and/or whether the test taker has a high priorityflag setting in the users profile, and/or whether the user has a timecommitment factor (for example, the user is about to board an airplaneflight), and/or the location of the user, and/or the local time of auser, and/or whether a doctor has provided expedited instructions,and/or a test takers determined anxiety level, and/or the like. Thesefactors can be selected so that a high degree of testing fidelity andaccuracy is maintained. That is, the system may offer express testingsessions only to users for whom, upon consideration of one or morefactors associated with the user, the system determines that there is ahigh probability of the user performing the test accurately with areduced amount of supervision. At the same time, the system can beoptimized such that express testing sessions are still reviewed byproctors and/or other components of the system to ensure sufficienttesting accuracy.

Before considering eligibility factors and system requirements forensuring testing accuracy, several aspects of an express testing sessionwill now be described with the understanding that not each and everyaspect need be present in all embodiments and that various modificationsare also possible. In general, express testing session can allow a userto perform a test with reduced proctor involvement when compared tostandard testing sessions. For example, during a standard testingsession, a proctor may walk a user through each step of the process ingreat detail, including even mundane or simple steps such as opening andarranging the testing materials. By contrast, in some embodiments,during an express testing session, the user may be only engaged by theproctor, if at all, during more complex or critical steps of the test.During an express testing session, for example, a user_may be allowed toperform various steps of the test and proctoring session withlittle-to-no proctor intervention. By decreasing proctor involvement, insome instances, testing duration may be decreased and/or testingcapacity of the system can be increased.

In some embodiments, a script or prompts provided to a proctor (to beread to a test-taking user) may be different or customized based on thetype of session being proctored. For example, a longer script or set ifprompts may be provided for standard testing sessions, while a shorterscript of set of prompts may be provided for express testing sessions.For example, in some embodiments, in an express testing session, theproctor may initially instruct the user to (i) perform the test and (ii)let the proctor know when the user is ready to submit their testingresults (which may still ultimately be interpreted by the proctor). Inthis case, proctor engagement with the user is limiting to an initialinstruction at the start of the session and verification of the testingresult at the end of the testing session. Other levels of proctorinvolvement can also be provided in an express testing session. Forexample, in some embodiments, proctor engagement only begins when theuser has completed the test and needs for the result to be verified. Inthese embodiments, proctor involvement may only occur at the end of thetesting session. In some embodiments, even though proctor engagement maybe limited, one or more proctors may still observe the user throughoutthe test (or during certain portions of the test) so as to be able toensure that the test is performed properly and step in with correctiveaction or additional instructions if necessary.

As another example, proctor involvement can be required only for certainor critical testing steps. In the case of a nose swab, for example,during an express testing session, a proctor may be required to watchthe swab occur so as to ensure that a sufficient swab depth is reached.In some embodiments, the user, during an express testing session, may beprovided with written and/or prerecorded video or audio instructions andthe proctor may only be involved with verifying that the steps areaccurately followed. By contrast, in some embodiments of a standardtesting session, a live proctor may read or walk a user through theinstructions before watching them perform the steps. Decreasing proctorinvolvement with express testing sessions can increase proctor capacityand improve overall throughput and efficiency of the system, allowingproctors to focus more of their time on new or inexperienced users thatare unfamiliar with the process, while allowing repeat or experiencedusers to perform certain steps on their own.

In some embodiments, during express testing sessions, a user may not berequired to remain on camera for the entirety of the session. Forexample, the user may only be required to appear before the cameraimmediately before and after taking the test and/or during certain orcritical testing steps. In some embodiments, the user may need to appearon camera prior to taking the test in order to verify their identity. Insome embodiments, the user may need to appear on camera after taking thetest to have the result verified by a proctor. In some embodiments, theuser may need to appear on camera during certain or critical testingsteps so that the system or a proctor can ensure that these steps areperformed with sufficient accuracy. In some embodiments, during anexpress testing session, the entire session (or certain critical steps)can be recorded such that the testing session can be audited to ensureaccuracy. Such auditing can be performed by a person (e.g., a proctorreviewing the video) or by the system (e.g., by using artificialintelligence or machine learning). In some embodiments, during anexpress testing session that is recorded, certain steps may be requiredto be viewed live by a proctor. These and other techniques which do notrequire a live or concurrent connection to the platform and/or a proctorat all steps of the testing session can be beneficial for severalreasons. For example, this can permit reduction in power and/orbandwidth consumption. Additionally, these techniques can permit testingwhere network access is limited and/or unreliable.

In some embodiments, no live proctor interaction with the user may berequired at all. This may not mean that no proctor is involved in thetest. For example, a proctor may supervise (e.g., watch video of)express testing sessions without interacting with (e.g., speaking to)the user. In such cases, the proctor may only engage with the user whenor if proctor engagement is requested by the user and/or if the proctorneeds to intervene to ensure that the testing is performed accurately.By not requiring the proctor to interact with users unless interactionis determined to be necessary, a proctor may be able to supervise ahigher number of testing procedures at once. This may also provideadditional benefits such as widening the range of environments wheretesting could occur. For instance, if proctors no longer need to bespoken to or heard due to the express testing format, users can taketests more easily in noisy airports, or even at home, work, or otherlocations without interrupting or disturbing those around them.Additionally, as mentioned above, this can reduce a bandwidthrequirement associated with testing, making testing more accessible byallowing more users to take tests on slower and/or less reliablenetworks, such as 4G or other slower connection speeds.

During express testing sessions, one or more proctors may be on standbyto answer any questions that a user might have and provide generaltesting oversight. Proctors may step-in or otherwise intervene during anexpress testing session if they spot the user performing a stepincorrectly or otherwise require additional information and/orparticipation from the user. As one example, a proctor may view aplurality of express testing sessions at once and only intervene withany particular user when necessary. In some embodiments, the proctorviewing the plurality of express testing sessions may not be the sameproctor as the proctor that intervenes. For example, a proctoringmonitoring a plurality of express testing sessions may realize that acertain user needs assistance and flag that user for intervention byanother proctor. In some embodiments, an express session proctor maymove a user from an express session to a standard session if it isdetermined that the user needs additional assistance. In someembodiments, an express session proctor may intervene and engage with anexpress session user directly, as needed, and maintain the user in theexpress session.

Determination of eligibility for participation in an express testingsession can be determined, in some embodiments, using a score-basedapproach. A wide number of factors can be considered in determining apatient's express testing session eligibility score. For example, duringa standard (or even an express) testing session, proctors may “rate” orotherwise provide an indication of their evaluation of a user'stest-taking proficiency at the end of the proctoring session. Suchratings can be considered in determining whether future testing sessionsof the user are eligible for participation in an express testingsession. In some embodiments, proctor scores of user proficiency may beprovided on a scale (e.g., a scale of 1-10, where one indicates that auser requires significant assistance and 10 indicates that a userrequires little to no assistance, a star-rating system (e.g., 1-5stars), etc.). In other embodiments, proctor scores of user proficiencymay comprises a binary indicator of whether the user isproficient/competent or not. Each system (scale-based or binary) canprovide advantages in certain scenarios. For example, a scale-basedsystem may provide data granularity that may allow the system to makemore nuanced determinations of eligibility, while the binary system maybe simpler to implement for proctors.

In some embodiments, users may also provide an indication of their ownproficiency and/or testing comfort upon completion of testing session(express or standard), using either a scale-based or binary system. Ofcourse, care should be taken to ensure that users ratings of themselvesare accurate. This can be achieved by, for example, comparing theuser-provided score with the proctor-provided score. Alternatively oradditionally, the platform may weigh the user's self-ratings againstself-ratings of other users in order to calibrate and standardizeself-ratings across the user-base. For example, if the user consistentlyrates themselves highly compared to other similar users (as determinedby the system or other proctor-defined skill ratings), the system mayadjust the user's self-ratings with a scaling factor to standardizeself-ratings across the platform. In some embodiments, a user'sself-ratings can also be compared against his or her own pastself-ratings. For example, if a user that has an average self-rating of5 after a number of past tests gives him or herself a self-rating of a 4in a current test, the system may determine lower the user's expresstesting eligibility since the change represents a large deviation frompast self-scores. This may occur even though a self-rating of 4 foranother user, who consistently self-rates at 4, may remain eligible forexpress testing. Alternatively or additionally, this can be providedusing machine learning and/or artificial intelligence by comparing theuser-provided score against one or more additional factors determined bythe system. Such factors could include for example, machine learning- orartificial intelligence-based analysis of a recorded video of patient'stesting session, analysis of durations taken by the user in performingvarious steps, etc. In some embodiments, the user may be given theopportunity to formally (or informally) attest to the truthfulness andaccuracy of their self-evaluation and/or agree to make a good faitheffort to complete every test administered on the platform in accordancewith the corresponding procedures, requirements, and guidelines.

Alternatively or additionally, a number of other factors could be usedto determine the user's score for eligibility to participate in anexpress testing session. For example, the score could be determinedbased, at least in part, on a number of times the user has taken thetest, how recently the user last took a test, etc. From this, it isapparent that express testing sessions would be beneficial for frequenttesters. For example, a frequent traveler may take tests often, becomingvery familiar with the process. On the other hand, users who seldom taketests or have not taken a test in a relatively long time may be lessfamiliar with the process, and thus more likely to benefit from beingreacquainted with the process by way of the standard testing session.Upon consideration of how many times, how frequently, and/or howrecently (possibly in conjunction with proctor-provided and/oruser-provided ratings and/or other factors), the system may determinethat the user is eligible for participation in an express proctoringsession.

In some embodiments, the score may also be determined based, at least inpart, on an assessment of how similar a user's current testingenvironment is to the user's previous testing environment. In general, auser repeating a test in an environment in which they have previouslytaken the test or an environment similar to an environment in which theyhave previously taken a test, may be eligible for or receive inincreased eligibility score for using an express testing session. Tothis end, in some embodiments, the user's eligibility score considersthe user's IP address and/or GPS data to determine the user's location,which is compared against previous testing locations. Similarly, thetype of user device the user is using may be identified and compared tothe type of user device that the user has used previously. For example,a user who previously performed the test using a laptop, but is nowattempting a test using a mobile phone, may not be eligible for expresstesting until they have qualified using a mobile phone.

In some embodiments, responses provided during a prequalification survey(such as the surveys described above) can also be considered indetermining whether a user is eligible for an express testing session.For example, during a prequalification survey a user may verify that heor she is a healthcare professional that is competent to administertheir own test. This may qualify the user for an express testingsession.

A score for each user can be determined and associated with that user'saccount. If the score generated for the user exceeds a predeterminedthreshold at the time the user signs in and attempts to initiate aproctoring session, then the platform can give the user the option toenter an express testing session or to enter a standard testing session.The user's score can be continually updated based on subsequent testingexperiences.

A user may, in some cases, be able to test in to establish eligibilityfor express testing sessions. For example, a user desirous ofeligibility for express testing can elect to take a test to show thatthey are eligible for express testing. Such testing can involve astandard testing session or a modified testing session.

The systems and platforms for at-home health testing and diagnosticsdescribed herein can be configured to allow at-home testing for a widevariety of health and diagnostic tests. In some instances, a user scorethat establishes eligibility for express testing sessions can bespecific to a certain test. In other instances, a user score thatestablishes eligibility for express testing can carry over to differenttypes of tests available on the platform. For example, a user who hastaken a nasal swab-based test several times and is eligible to useexpress testing session for that test may also be eligible to use anexpress testing session when taking a mouth swab-based test, even, insome cases, for the first time the user takes the mouth swab-based test.In other cases, the user may become eligible for express testing for newtests only after taking the new test using a standard testing session.Still, the user's score could decrease the requirement for the user tobecome express eligible for the new test. For example, the user (who hasexperience on the platform with a nose swab-based test) could becomeeligible to use an express testing session to take the mouth swab-basedtest after only taking said test once (whereas a user who has never usedthe platform may be required to successfully take the mouth swab-basedtest three times before becoming eligible for express testing sessions).

In some instances, however, in some examples, a same user may not enjoythe same eligibility reciprocity/recognition when trying a test that isradically different from the nasal swab-based test, such as a test whereblood sample collection is required. For example, a user's expresstesting session eligibility score may be associated with a specific test(e.g., a nose-swab), a specific type of test (e.g., swab-based, whethernose or mouth, or minimally invasive tests), or with all tests availableon the platform. In some embodiments, the user has the option whether toenter an express testing session or a standard testing session whentaking a test, such that a qualified user has the opportunity to choosethe most convenient and comfortable session for them.

In some cases, a user's express testing session eligibility can berevoked for testing infractions (e.g., performing one or more stepsincorrectly, trying to rig the test, submitting fraudulent test results,etc.). This can be done to maintain the integrity of the platform as awhole. Accordingly, even in express testing sessions, it can beimportant to have a level of oversight and/or verification, which can beprovided live (concurrent with the testing session) or after the fact(by, for example, reviewing recording, photos, or other data collectedduring the testing session). Moreover, the oversight and/or verificationcan be provided by live (e.g., proctor-based) or artificialintelligence- or machine learning-based review.

For implementations in which a score is generated for each user, a givenuser's score may be negatively impacted for testing infractions, whichcould lead to the user's express testing eligibility being revoked(e.g., as the score drops below a predetermined threshold value). Moresevere infractions can more negatively impact a user's score.Additionally or alternatively, a duration of the revocation could, insome examples, vary based on the severity or nature of the infraction,the user's history of infractions (e.g., a three strikes and you're outtype policy), etc. As an example, a user who attempts to submitfraudulent test results may have their express testing eligibility (oreven their standard testing eligibility) permanently revoked, while auser who forgets to wash their hands before taking a test may only havetheir express testing eligibility temporarily suspended (e.g., the usermay be required to participate in the standard proctoring session thenext time they take a test using the platform, but may regaineligibility immediately thereafter). In some instances, the user may benotified of the reasons associated with loss of express eligibility (ora decrease in their user score) and given opportunities to remediate thecause of the infractions. For implementations in which a score isgenerated for each user, the extent to which a user's score isnegatively impacted by testing infractions may vary based on suchfactors as type and severity of the infraction.

In some embodiments, users who are already established as eligible forexpress session testing may be required to participate in the standardproctoring session periodically, even in cases where no testinginfractions have incurred. For example, users that would otherwise beeligible for express testing session may be required to participate inthe standard proctoring session the next time they take a test using theplatform if, for example, the test kit has changed since the last timethey took the test (e.g., the packaging has changed, the shape/design ofitems in the test kit have changed, etc.). As another example, usersthat would otherwise be eligible for express testing session may berequired to participate in the standard proctoring session the next timethey take a test using the platform if the testing procedure and/or FDArequirements have changed since the last time they took the test (e.g.,users were previously required to add six drops of reagent solution to atest strip, but are now required to add eight drops of reagent to thetest strip for enhanced accuracy). As another example, users that wouldotherwise be eligible for express testing session may be required toparticipate in the standard proctoring session the next time they take atest using the platform if the proctoring session protocols have changedsince the last time they took the test (e.g., users were previouslyasked to hold the testing materials up to the camera on their laptop toshow the proctor their results, but are now required to instead leavethe testing materials on the table, snap a photo of the testingmaterials on their smartphone, and submit the photo to the proctorthrough a downloaded or web-based version of an application on theirsmartphone).

Additionally or alternatively, users that would otherwise be eligiblefor express testing session may be required to participate in thestandard proctoring session periodically or randomly to ensureeligibility for express testing.

Although generally having been described as a binary system of expresstesting sessions and standardized testing sessions, this need not be thecase in all embodiments. For example, express testing may involvemodification or expedition or one or more of the steps of a standardizedtesting session. That is, in some embodiments, hybrid testing sessionsmay be provided that are tailored to the user's level of test-takingexperience on a step-by-step basis. Referring once again to the exampledescribed above in which users were previously required to add six dropsof reagent solution to a test strip, but are now required to add eightdrops of reagent to the test strip for enhanced accuracy, in someembodiments, the proctor may only provide the “standard” proctoringexperience for the step of the test in which the user is required to addthe reagent solution to the test strip, and may otherwise provide anexpress proctoring experience for the other steps of the test (whichhave not changed). As another example, an express testing experience canbe provided for simpler steps, while a standard, more involved testingexperience can be provided for more complex or critical steps. In someembodiments in which an express testing session includes both steps thatare not and steps that are directly monitored by a live proctor, thesystem may be configured to provide a cue (e.g., a visual or audio cue)to identify or distinguish between these steps. For example, when a userarrives at a step that requires proctor involvement, the user may bealerted (via the cue) to wait for proctor engagement.

In some embodiments, a user that has qualified for express testing maybe given a “badge” or other indicator that appears next to theirusername when they become eligible for express testing sessions. In somecases, one set of proctors give standard testing sessions and anotherset of proctors give express testing sessions. In other cases, proctorsmay give both standard and express testing sessions simultaneously. Inthese cases, a badge or visual indicator may help visually distinguishexpress users from standard users. Additionally, in some embodiments,upon qualification for express testing (or upon disqualification), theuser is notified of the change in status. Such notification can occur,for example, during a testing session, after a testing session, or atthe start of a subsequent testing session.

FIG. 26 illustrates an example flowchart for providing standard testingsessions and express testing sessions according to some embodimentsdescribed herein. At 2602, a testing session is initiated. Initiation ofthe testing session can be begun by a user, for example, when a usercreates or logs into their user account and selects to initiate a test.At 2604, the system, platform, or a proctor may make a determination ofthe user's eligibility for participation in an express testing session.As described above, this determination may be based on a number offactors using a score-based approach. For example, in some embodiments,one or more scores generated for the user may be evaluated against oneor more thresholds to determine the user's eligibility at 2604. If it isdetermined that the user is eligible for participating in an expresstesting session, at 2606, the user is presented with options toparticipate in either an express testing session or a standard testingsession. In some embodiments, this step can be omitted and the user canbe taken to an express testing session upon determination ofqualification. If the user elects to participate in an express testingsession, at 2608, the user is provided an express testing session. Asdescribed above, in certain scenarios, the user may be removed from anexpress testing session, for example, if it is determined that moredirect proctor supervision is needed (either by the system, a proctor,or the system). In such cases, as indicated by the arrow extendingbetween 2608 and 2610, the user may transition from an express testingsession to a standard testing session midtest. As noted above, suchexpress testing session, may involve less, little, or no proctorengagement or involvement when compared with a standard testing session.If the user that has been determined to be eligible for express testingelects to proceed with a standard testing session, at 2610, the user isprovided with a standard testing session. Returning to 2604, if it isdetermined that the user is not eligible for participation in an expresstesting session, at 2610, the user is provided with a standard testingsession. From 2608 (an express testing session) or 2610 (a standardtesting session), during or upon completion of the testing session theuser is evaluated and/or verified at 2612. Evaluation or verificationmay provide data that can be used to determine future eligibility forexpress testing. At 2614, such data can be saved for future use, suchthat it can be used at 2604 when a subsequent test is initiated todetermine eligibility for express testing.

User-Proctor Matching

As described previously, the testing platform described herein can beconfigured to allow for a plurality of users to perform remote healthand diagnostic testing under the supervision of one or more proctors. Asusers access the platform, they can be matched with certain proctorsbased on various criteria selected to improve the users' testingexperience and/or to improve the efficacy of the proctors. In someembodiments, users accessing the platform are placed in a user pool andproctors accessing the platform are placed in a proctor pool. Variouscriteria can be determined for each of the users and for each of theproctors. These criteria can then be analyzed to match or assign usersto certain proctors. For example, such criteria can be evaluated at 116of FIG. 1 and/or at 308 of FIG. 3 (described above) in order to match orassign users to proctors.

Users may be matched with or assigned to proctors based at least in parton one or more of a variety of different factors. Such factors mayinclude, for example, the languages spoken by the users and theproctors, user disabilities and/or special needs, user and proctorlocation, types of tests to be taken or administered, a user's level oftechnical proficiency, proctor availability, strength of networkconnection, and/or a level of testing, verification, or scrutiny desiredor required.

For example, users may be matched or assigned to a proctor based on alanguage spoken by the user. The testing platform may be provided inmultiple languages and available all over the world. Accordingly, usersaccessing the platform may speak a variety of different languages. Tofacilitate testing, proctors may be provided in languages thatcorrespond to the languages of the user. When an English-speaking useraccesses the platform, they may be assigned to an English-speakingproctor. When a Spanish speaking user accesses the platform, they may beassigned to a Spanish speaking proctor. This can ensure that theproctored testing session can run as smoothly as possible ascommunication barriers between the users and the proctors can bereduced.

In some embodiments, the language desired by the user for the proctoredtesting session may be indicated by the user. For example, whenaccessing the platform, the user may create a user profile in which theuser's language preference is indicated. In some embodiments,multi-lingual users may indicate that they can speak more than onelanguage and may even indicate a proficiency for each language. Whenmatching such users to proctors, each language and proficiency may beevaluated in view of the available proctors in order to find a matchingproctor as quickly as possible. For example, if a user indicates that heor she is a native Spanish speaker but is also fluent in English, theplatform may first check to see whether a Spanish speaking proctor isavailable. If a Spanish speaking proctor is available, the user may bematched to the proctor. If a Spanish speaking proctor is not available,the platform may then check whether an English-speaking proctor isavailable, and if so, match the user with the English-speaking proctor.

In some embodiments, the platform may attempt to automatically determinethe user's language. For example, the platform may analyze the user'snetwork connection (e.g., the user's IP address) in an effort todetermine where the user is geographically located. If, for example, theuser's IP address is associated with a typically English-speakinggeographical location, the user may be initially presented with anEnglish-speaking proctor. If the user's IP address is associated with atypically Spanish speaking geographical location, the user may beinitially presented with a Spanish speaking proctor. Other factors mayalso be analyzed in an effort to automatically determine the user'slanguage. For example, an estimate of the user's language may be madebased on a top-level domain associated with the testing platform'swebsite accessed by the user. For example, if a user accesses thetesting platform at www.[testingplatform].mx (.mx being the top-leveldomain associated with Mexico), the testing platform may make an initialdetermination that the user likely speaks Spanish. In such cases wherethe platform attempts to automatically determine the user's language,the user may be given the option to change to a more preferred languagein the event that the automatically determined language is incorrect.

Proctors may also be associated with profiles that provide informationabout the proctors that is used to match the proctors to the users. Aproctor profile can include information about which languages are spokenby each proctor as well as a proficiency score for each language. Insome embodiments, proctors can specify which languages they speak aswell as their proficiency in each language. In some embodiments,proctors may be required to take language tests to ensure that they aresufficiently proficient to provide a proctored test in a given language.In some embodiments, the platform may analyze proctor performance andadjust a proctors proficiency score for each spoken language. Forexample, a proctor may indicate that he or she is fluent in English andSpanish. The platform may thus assign both English speaking users andSpanish speaking users to the proctor. The platform may analyze theproctor's proficiency in providing proctored testing sessions in Englishand Spanish. For example, the platform may track an average testingsession length for both the English and Spanish sessions. Upondetermination that the proctor takes sufficiently longer to provide aproctored testing session in one language when compared to the other,the platform may lower the user's proficiency score for the slowersession language. Additionally or alternatively, the platform mayevaluate testing accuracy for each of the proctor's spoken languages.For example, if it is determined that tests administered by the proctorin Spanish generally are more accurate than tests administered by theproctor in English, the platform may assign more Spanish speaking usersto the proctor. As a result, the platform may assign more users whospeak the proctor's faster language to the proctor in the future. Insome embodiments, in addition to or in place of comparing the proctor'sproficiency against itself (e.g., comparing the proctor's Englishproficiency against his or her Spanish proficiency), the platform mayalso compare the proctor's proficiency against that of other proctors.In this way, the platform can dynamically balance matching users toproctors in the most efficient manner.

Another factor that may be considered by the platform in matching orassigning users to proctors can be disabilities or special needs of theusers. For various reasons, some users may require specialaccommodations in order to take a test. The platform can consider theusers' needs and provide the user with a proctor equipped to provide thenecessary accommodations. As one example, a user that is hard of hearingor deaf can be assigned to a proctor that is proficient in sign languageor to a proctor that is proficient in communicated with the user throughtext. Users accessing the platform may provide information about anyspecial needs or disabilities as well as desired or necessaryaccommodations that must be made to facilitate the testing session. Forexample, such information can be entered during creation of the user'sprofile or account or gathered during a pre-qualification survey, forexample as described at 104 and 106 of FIG. 1. Similarly, proctorprofiles can store information about skills or accommodations that aproctor can provide. Similar to the proctor language informationdescribed above, a proctor's ability to accommodate a disability orspecial need can be evaluated by the platform. For example, testingsession duration and/or accuracy of test results can be analyzed andused to rebalance proctor assignment over time such that that proctorscan be assigned and matched to users in a manner that maximizes theoverall efficiency of the system.

In some embodiments, the platform may match users to proctors based onthe location and/or time zone of the users and proctors. This mayimprove the testing experience by matching users to proctors that areclose to them geographically or in the same time zone.

In some embodiments, proctors and users can be matched based on the typeof test to be taken. As noted above, the platform may be configured toallow for a wide variety of remote health tests or other diagnostics.While users accessing the platform may generally do so in order to takea specific kind of test, proctors may be able to administer more thanone type of test. For example, a proctor may be able to provide aproctored testing session for a first type of test and also to provide aproctored testing session for a second type of test. Proctor profilesmay include a list of each type of proctored testing session that can beprovided by a given proctor. In some embodiments, proctors may need totake specific training and/or receive certain verifications to providedifferent types of proctored testing sessions.

In some embodiments, proctors that are certified or otherwise able toprovide different types of proctored testing sessions can be evaluatedby the platform such that users are assigned to the proctor in anefficient manner. For example, if both a proctor A and a proctor B arecapable of administering a first type of proctored testing session and asecond type of proctored testing session, the platform may evaluateproctor A and B's proficiency with each type of testing session andmatch users accordingly. For example, the platform may determine thatproctor A provides the first type of proctored testing session morequickly than proctor B does. The platform may then assign users taking atest associated with the first type of proctored testing session toproctor A and assign users taking a test associated with the second typeof proctored testing session to proctor B.

Another factor that can be considered by the platform in assigning usersto proctors may be the users' technical ability or proficiency. As anexample, an older user may not be as technically proficient as a youngeruser. Certain proctors may have more proficiency in providing proctoredtesting sessions to such older users. Accordingly, the platform mayassign such older users to such proctors. In some embodiments, the usersthemselves may provide an indication of their technical proficiency. Forexample, during user account creation or a pre-qualification survey, theuser may input a technical proficiency score or a comfort scoreassociated with using the remote testing platform. In some embodiments,the platform may make a determination about a user's technicalproficiency based factors observable by the system. For example, thesystem may make a determination about a user's technical proficiencybased on an amount of time take by the user to set up his or her accountor to complete the pre-qualification survey. As another example, theplatform may make a determination about the user's technical proficiencybased on the user's age or other factors. In some embodiments, thesystem may automatically administer a short test to the user todetermine technical proficiency, for example, by checking whether theuser is able to operate his or her webcam, microphone, and speakers.

As before, the platform may continually or periodically evaluate proctorproficiency in providing proctored testing sessions to less technicallyproficient users. For example, the platform may analyze elapsed sessiontimes or test result accuracy for various proctors and assign lesstechnically proficient users to proctors that can most efficiently andaccurately administer tests to such users.

The platform may also consider the strength of users' and proctors'network connections in determining how to assign and match the users andproctors. For example, the platform may evaluate or determine aninternet speed, latency, and/or reliability of the network connectionfor each user and proctor. This information can be used to matchproctors and users in a manner that ensures that a stable connectionbetween a user and proctor can be maintained during a testing session.

In some embodiments, the platform may also consider a level of testingverification or scrutiny that is required or desired in determining howto assign and match users to proctors. For example, in some instances, acertain level of proctor scrutiny or involvement may be required tocomplete and validate a test result. For example, government or otherregulatory bodies may require certain steps to be completed in order tovalidate a test. In such cases, users can be matched with proctors thatare capable of providing the needed level or scrutiny. In other example,users may request a certain level or proctor involvement or scrutiny.For example, a user that is generally unsure or uncomfortable withremote testing procedures may request a more involved proctoringsession.

Accordingly, users who require or desire a proctoring session withadditional verification measures or a higher level of testing scrutinymay be matched with proctors who conduct one-on-one proctoring sessionsand/or can provide additional verification services. As one example,users who need verified passes in order to comply with CDC rules or lawsmay be matched with proctors capable of providing such services. Asanother example, in some embodiments, users may pay for a premiummembership/service for the platform that automatically communicates theusers' test results to user-specified entities. For example, theplatform can provide users with a with a TSA Pre-Check-like pass servicewhere the user provides additional verification information and performsadditional verification processes with the proctor in exchange for apass that allows users to “skip the line” or otherwise more seamlesslytravel or access various venues and other locations.

The system may also consider proctor availability in matching users andproctors. As noted above, the platform may consider various factors inmatching users and proctors to improve the efficiency and accuracy ofthe platform. In some embodiments, however, the most efficient proctorsmay not be available. Accordingly, the platform can further considerproctor availability. For example, in some embodiments, it may be fasterto assign a user to a less proficient proctor with a shorter wait time,rather than assigning the user to more proficient proctor with a longerwait time.

The platform may dynamically match proctors and users upon considerationof one or more of the factors described above as well as others.Further, the platform may continually or periodically evaluate theefficiency and accuracy of proctors based on each of these factors anduse this information to continually rebalance and recalibrate theplatform to maximize efficiency. For example, the platform may adjusthow users are assigned to proctors to reduce testing session timesand/or improve testing session accuracy by assigning proctors to usersin the most efficient manner.

Additionally, the order in which users are placed in queues for meetingwith proctors may be determined based at least in part on one or more ofa variety of factors. As noted above, in some instances, a user may beplaced into a waiting room while waiting for a proctor to be assigned orwhile waiting for an assigned proctor to become available (see, forexample, FIG. 9, which is described above). The order in which users arematched to proctors and/or assigned to available proctors may also beconsidered by the system. For example, in some embodiments, a level oftesting urgency or priority associated with each of the various usersthat are to meet with proctors may be considered. The level of testingurgency or priority that is associated with a given user may be afunction of one or more of a variety of parameters. These factors mayinclude, for example, how soon the user will be boarding a flight,whether the user is crossing a state or international boarder, howat-risk the user may be, how symptomatic the user may be, the user'scurrent test pass status, the user's occupation or other status, thetime spent waiting in queue, and/or a user's membership tier associatedwith the user platform, among others.

For example, a user that is about to board a flight or travel acrossstate lines or other boarders may be given an advantageous place in thequeue in an effort to assure that the travel can be completed. Asanother example, a more at-risk user may be given an advantageous placein the queue to minimize his or wait time. An at-risk user may be onethat has a pre-existing condition or is elderly. For example, theelderly and people with certain health conditions may be placed ahead ofothers in the queue in order to ensure that they can be tested as soonas possible. As another example, a more symptomatic user may be given anadvantageous place in the queue. People who are exhibiting worrisomesymptoms may be placed ahead of others in the queue so that they canreceive the medical attention they might need sooner. This can improvehealth outcomes for the particular patient as well as minimize thespread of a contagious disease to others.

A user's place in queue may be assigned in part based upon whether ornot the user has a test pass that is currently valid and/or the amountof time remaining until expiration of a user's current test pass. Forexample, people who do not have test passes that are currently valid andpeople who have test passes that will be expiring shortly may be placedahead of others in the queue. The user's occupation or other status mayalso be considered in determining queue placement. For example, doctorsor medical personnel may be placed ahead of others in the queue.Additionally, time spent waiting in queue may also be considered. Forexample, users who have not been waiting for very long may be placedbehind users in the queue who have been waiting for a while. In someembodiments, the platform may provide premium memberships or servicesthat can affect a user's placement in the queue. For example, users thatpay for a premium membership or service may be placed ahead of others inthe queue.

The user-proctor matching and user queuing techniques and featuresdescribed above have generally been presented in the context ofassigning users to proctors for proctored based testing sessions.However, in some embodiments, different proctors may be provided fordifferent portions of a proctored testing session. Accordingly, theuser-proctor matching and user queuing techniques and features describedabove can be implemented at different stages in proctored testingsession along the process. For example, a user may be shifted todifferent proctors throughout a test, with different proctors providingdifferent stages or steps in the process. Proctors can be evaluated forproficiency and accuracy in providing the different stages of the tests(in some embodiments, for different types of users), and users andproctors can be matched accordingly.

In some embodiments, some phases or steps in a testing process mayrequire more direct supervision, while other stages may require lesssupervision. In some embodiments, during stages that require more directsupervision a lower ratio of proctors to users may be used, while instages that require less supervision a higher ratio or proctors to usersmay be used. Proctors can be evaluated to determine whether they aremore proficient in proctoring the steps that involve supervision of ahigher number of users or in proctoring the steps that involvesupervision of a lower number of users, and the platform may match usersand proctors accordingly.

FIG. 27 provides a flowchart of an example process that can beimplemented in the platform for matching users to proctors and improvingthe efficiency and accuracy of the platform. As shown in FIG. 27, at2702, a user accesses the platform. The user may access the platformremotely over a network using a user device as described above. At 2704,information regarding the user may be determined and stored in a profileassociated with the user. User information may be determined, forexample, during an account creation or pre-qualification survey step inwhich the user responds to one or more prompts to provide informationabout the user. In some embodiments, the platform may determineinformation about the user based on information available to theplatform, such as information about the user's network connection.Information about the user may include, for example, information aboutlanguages spoken, disabilities or accommodations needed or requested,location and/or time zone, type of test to be taken, an assessment ofthe user's technical proficiency, information about the user's networkconnection (e.g., speed, latency, reliability, etc.), and/or a desiredor required level of testing scrutiny, among other types of information.

At 2706, proctors access the platform. The proctors may access theplatform remotely over a network using a proctor device as describedabove. At 2708, information regarding the proctor may be determined andstored in a profile associated with the proctor. In some embodiments,proctor profile information is input by the proctor. In someembodiments, proctor profile information is determined by the platform,for example, based on previous proctored testing sessions provided bythe proctor. In some embodiments, the information about the proctor mayinclude, for example, information about languages spoken, disabilityaccommodations the proctor can provide, location and/or time zone, typesof test to be administered, and/or information about the proctor'snetwork connection (e.g., speed, latency, reliability, etc.), amongother types of information.

At 2710, users and proctors are matched for proctored testing sessionsbased on an analysis of one or more matching criteria by the platform.For example, the platform may consider the information stored in theuser and proctor profiles and match users to proctors in a manner thatmaximizes the efficiency of the system as described above. At 2712, aproctored testing session is provided to the user based on the matchingestablished at 2710. At 2714, the efficiency and/or accuracy of theproctored testing session can be analyzed by the platform and used toupdate the user profile, at 2716, and/or the proctor profile at 2718.For example, if the testing session takes longer than expected ordesired, the proctor profile may be updated such that the proctor willnot be matched with that type of user in the future. In this way, theplatform can continually evaluate proctors and users and match them in amanner that maximizes the efficiency of the system.

Test Integrity and Verification

In some embodiments, during a remote testing procedure, various stepscan be implemented before, during, and after the test in order to ensuretest integrity and verify the result of the test. For example, beforethe test is taken, it can be desirable to verify the user's identify andto verify that the test kit is valid (e.g., to verify that the test kitis one that has been purchased or otherwise obtained through an officialchannel, has not expired, and has not been previously used). During thetest, it can be desirable to verify that any sample obtained is actuallyobtained from the previously verified user and that all testinstructions and procedures are followed correctly. Finally, after thetest, it can be desirable to ensure that the test result is obtainedfrom the previously verified test kit and to ensure that the test resultis interpreted correctly.

As noted above, it can be important to verify the user's identity beforethe test is taken. This can be because it ensures that the results willbe attributed to the correct person. Verifying the user's identity isparticularly important in cases of remote testing as the person beingtested is not physically located with the person administering the test.Thus, in many situations, extra precaution may be advantageously takento correctly identify the user's identity. Verification of the user'sidentity can be accomplished in several ways. For example, the user canbe asked to upload a copy of an official identification (e.g., adriver's license or passport) as part of an account creation orpre-qualification step. In some embodiments, the user may be asked toshow the official identification to the proctor during the testingsession. During the testing session, the proctor can then compare theuploaded or shown identification to the person's appearance in the videofeed. In this way the proctor can verify the user's identity bycomparing a live (or other) video feed of the user to an identificationcard associated with the user. In some embodiments, once the user'sidentity is verified, the user's identity can be associated with theuser's account for future tests. For example, after verification, futureverifications may be automated with face matching technology.

In another example, user identification can be achieved usingbiometrics. For example, in some embodiments, a user accessing theplatform may be given the option to perform a biometric initialization,in which the user goes to a physical location where their fingerprint ora unique segment of DNA can be sampled and stored. Thereafter, everytest taken can sample their fingerprint or DNA to verify identity. Thismay also be automated. In other embodiments, biometrics may be performedusing biometric features of the user's device. For example, manysmartphones today are capable of taking a user's fingerprint orrecognizing a user's face. These features may be used to verify theuser's identity in some embodiments.

In addition to verifying the user's identity, the test or test kit thatwill be used during the test may be verified as well. This can beimportant because it ensures that the test results are scientificallyvalid and can be trusted. Again, this can be particularly important inthe case of remote testing where the user is not physically located withthe person administering the test. In one embodiment, the test or testkit can be provided with a unique ID (e.g., a UID or serial number)assigned during manufacture, which can be queried when the test istaken. This can take the form of a printed string of characters,barcode/QR code, NFC/RFID tag, or other. This code may either explicitlyencode information associated with the test (such as a test identifier,test expiration date, batch/lot codes, indication of whether this numberhas been used for a test or not) or it may encode a link to a databaseentry that includes such information. Prior to beginning the test, thecode may be scanned to verify the test kit. If anything is amiss, thetest does not proceed and the user may be instructed to obtain a newtest kit. In some embodiments, it may be preferable to provide theunique ID in a non-human readable manner. This may provide an advantagein that they are harder to misrepresent. A visible code could beduplicated and used on an expired test, for example.

During a test, a sample may be collected from the user, for example,using the test kit. To ensure the integrity of the test, steps may betaken to ensure that the sample is actually collected from the same userwhose identity was verified before beginning the test. Again, this canbe especially important in the case of remote tests since the user isnot physically located with the person administering the test. It can beimportant to ensure that a user does not swap in a sample obtained fromanother user when performing the test. Various mechanisms for verifyingthat the sample is collected from the previously verified user arepossible. For example, during a proctored testing session, the proctor(or an automated system) can observe the sample collection process. Forexample, in the case of a nasal swab test, the proctor or the automatedsystem can observe the user performing the swab procedure. Suchobservation can be performed live (e.g., over a live video connection)or through a pre-recorded video. In either event, it may be importantthat all sample collection materials remain in view of the camera at alltimes. This would prevent a user from swabbing his or her nose and thenswitching out the swab with another that has been used by a differentperson. Additionally, it may be beneficial to positively identify theuser during the collection process. This can be accomplished by, forexample, checking the user's identity immediately before the samplecollection process.

During the test, it is also important to ensure that all testinstructions and procedures are followed correctly. This can ensure theaccuracy and validity of the test results. Similar to verifying that thesample is obtained from the correct user, ensuring that all testinstructions and procedures are followed correctly can be accomplishedby directly viewing the testing procedure, either over a live video feedor be watching a recording of the testing process. In some embodiments,such observation is provided by a live proctor. In some embodiments,such observation is provided through an automated system (e.g., acomputer system that is configured analyze live or pre-recorded video).In the case of a swab, for example, as shown in FIG. 28, the swab caninclude stripes or other markings 2802 along its length to be able toquantify swab insertion depth in an orifice, such as a nostril. In thismanner, a proctor can easily observe that the swab is inserted to asufficient depth. Additionally, the automated system can be configuredto recognize the stripes or markings 2802 on the swabs in the video toautomate determination of proper insertion depth. In some embodiment, inwhich test a test must sit for a certain amount of time (e.g., dwellexample), the user can be instructed to place the test on a suitablesurface in view of the camera for an appropriate amount of time. Theproctor or system can observe that the test is placed on the appropriatesurface and remains in view during the entire dwell length. In the caseof a nasal swab COVID-19 test, for example, an appropriate amount ofliquid may need to be added to a testing card, a nasal swab may need tobe inserted into the nostril to a sufficient depth, the swab must thenbe correctly applied to the liquid on the card, and the card must beleft undisturbed on a flat surface for at least fifteen minutes. Each ofthese steps can be observed and verified by a proctor and/or anautomated system to ensure the integrity of the test.

Additionally, it is important to ensure that submitted test resultsactually come from the originally verified test or test kit. This canensure test continuity, making sure that the same test is usedthroughout the test (e.g., that the test that was verified is the onefor which results are obtained). Otherwise, tests could be exchangedduring the process, leading to improper results. In some embodiments,this can be accomplished by reverifying the test or test kit throughoutthe testing procedure. For example, the method that was used previouslyto determine the test kit was valid (e.g., scanning the unique ID of thetest kit) can be repeated to ensure the UID/serial number are the same.In some embodiments, the test kits can be designed such that the testsuch that the results are reported in a manner that includes theUID/serial number, such as in a custom visible code (barcode, QR code,etc.) or NFC/RFID, so that when the results are read, the UID can beverified. For example, in some embodiments, test results are verified byviewing strips that appear on a test card. The test card can include theunique ID of the test kit near the area at which the strips will appearsuch that a view of the strips also includes a view of the unique ID.

Finally, it can also be important to ensure that the test results areinterpreted correctly. As described previously, in some embodiments, aproctor interprets the test results by viewing strips that appear on atest card, for example, as described above with reference to FIG. 12. Insome embodiments, an automated system may interpret the test results. Insome embodiments, the test results can be reviewed and verified byanother proctor or automated system to provide a second layer ofverification.

Test Pass

A test pass can be provided and associated with the platform that isused to identify the user and communicate the user's test results. Insome embodiments, the test pass can be provided at and/or used to verifya user's identity at a point of care, such as the location where thetest is taken (e.g., a medical facility, a home, a hotel, an airport, aetc.), and also used to verify the user's test results at a point ofverification (e.g., a location where the user's results are checked(such as the airport, a hotel, a place of employment, etc.). In someembodiments, the point of care and the point of verification may bedifferent. For example, a user may take the test at his or her home andreceive the test pass and then can use the test pass to verify his orher results at the airport. In some embodiments, the point of care andthe point of verification may be the same. For example, a user desiringto board a flight at an airport can take a test and receive a test passat the airport and then use that pass to verify the results and board aflight.

In some embodiments, the test pass can be configured to perform one ormore of several functions. For example, the test pass can include proofof the user's identity. For example, in FIG. 5, the test pass includespersonal information 502. The personal information can include theuser's name and other identifying information such as photo or otherbiometric information. The test pass can be configured to show thisinformation to prove the user's identity at a point of care (e.g., atmedical facility or home at which the test is taken) and at point ofverification (e.g., at an airport, stadium, etc., where the test resultis checked). In some embodiments, the test pass includes a positiveidentifier that checks or verifies the user's identity against adriver's license, passport, or other verifiable biometric data. Inpreferred embodiments, identity verification using the test pass shouldbe simple and quick. Additionally, the test pass should be configuredsuch that the results reported by the pass should be able to be trustedat point of verification. For example, the test pass can ensure thatresults stored on the pass were gathered using an FDA-approved method.The test pass can also be configured for information security. Forexample, the test pass can provide the user with a mechanism forcontrolling who accesses their data and when.

A test pass can be provided in either a physical or virtual manner. Forexample, a physical test pass may comprise forgery-resistant cardprovided by the test pass issuer that includes user's name and photo foridentification. The physical test pass may also include a barcode, QRcode, NFC chip, contact chip, alphanumeric code, or other uniqueidentifier that will access test results from a secure database whenscanned. An example is shown in FIG. 5, described above. A virtual testpass may be available over a computer network or through an application.When accessed, it can display a scannable code or use NFC or other meansfor quick communication at point of verification. In some embodiments,the test pass can be linked to a user's existing ID. For example, testresults can be linked to an existing form of ID by name and uniquenumber (driver's license number, passport number, etc.). The user musthave this ID at point of care and point of verification, where theirname and unique number are used to access results from a securedatabase.

In some embodiments, each user is provided with a new physical orvirtual test pass each time they complete a test. For example, a usermay be provided with a new physical test pass indicating the most recenttest result, or the user may be provided with a virtual test passindicating the most recent test result. In other embodiments, in whichthe user already has a test pass, upon completion of a new test, theexisting test pass can be updated to include the most recent result. Forexample, a machine-readable code on a physical or virtual test pass maybe linked to the newest test result.

In some embodiments of a virtual test pass, the user's ID may beverified each time that the virtual test pass is displayed. For example,the user may be required to be biometrically authenticated each time thevirtual test pass is to be displayed. As one example, the user may useface recognition on his or her phone in order to verify his or heridentity before the virtual test pass can be displayed.

Test Continuity

As described above, the remote testing platform described herein canconnect remotely located users with proctors over a network such as theinternet. Problems may arise if either the users or the proctorsexperience poor network connectivity. The platform, however, mayimplement certain mechanisms and procedures to facilitate remote testingeven in circumstances of poor network connectivity. For example, ifeither the proctor or the user experiences connectivity issues duringthe proctoring session, the proctoring session may be prematurelyterminated, which can be inconvenient for users. However, the platformcan be adapted to detect a loss of connection and/or poor connection,and take steps to record images or video of the user and test kit sothat testing and proctoring can be resumed if and when connectivity isrestored.

The platform may evaluate the strength of the user's network connection.In response to determining that the user's connection has dropped out orslowed down dramatically, the platform may perform one or moreoperations to begin recording and storing image or video data to a locallocation (e.g., on the user's hard drive). For example, the user may beparticipating in a live proctored testing session in which they areactively connected to a live proctor over video. During the session, theplatform can monitor the user's network connection. If certain thresholdcriteria are met, indicating that the user's network connection isunstable or insufficient, the platform may initiate a recording of theuser's session. In some embodiments, detection of a network connectivityissue may trigger high full frame rate resolution recording. In someembodiments, the recording is initiated and stored on the user's localmachine, such that a network connection is not required for therecording. Depending on the type of test being performed and/or thelevel of proctor involvement necessary, the testing session may be ableto continue, even though the user has lost his or her network connectionto the proctor. For example, the user may be provided with prerecordedor written instructions for completing the testing session. Uponregaining connectivity, the recorded data may be uploaded to theplatform and provided for proctor (or automated review). For example,once network connectivity is restored, the user's video may be uploadedto the platform where it can be reviewed by a proctor (or an automatedsystem) to determine whether all testing steps were accurately followed.If all testing steps can be verified, the user's test result can also beverified. If one or more of the testing steps cannot be verified, theuser may need to redo the test.

In addition to monitoring the user's network connection, the platformmay also monitor the proctors' network connection. If a proctor'snetwork connection is determined to be unstable or slow, the platformmay perform one or more operations to ensure or facilitate testcontinuity for users connected to that proctor. For example, theplatform may begin recording and storing user image or video data tocloud storage such that the proctor may review the image or video datawhen his or her network connection is restored. In some embodiments,detection of a network connectivity issue may trigger high full framerate resolution recording. In some embodiments, the platform may sendthe recorded image or video data to another proctor or an automatedsystem for review such that the user can continue the proctored testingsession without delay. For example, the image or video data may bereviewed (in real-time) using an automated system or by anotheravailable proctor. When the original proctor regains networkconnectivity, in some embodiments, the proctor may be given access tothe recorded data for review. In some embodiments, upon determining thata proctor's network connection is unstable, slow, or otherwise notworking, one or more users connected to that proctor may be redirectedto other proctors. In some embodiments, a backup proctor may beconnected to the testing session such that the backup proctor canseamlessly take over in the event that the initial proctor becomesunavailable.

In the event of network connectivity issues (either on the user end orthe proctor end), the platform may display messages to the user or theproctor indicating the potential issue and the steps being taken toensure or facilitate testing continuity. For example, the user may beprovided with a notification regarding the connectivity issues,instructions on how to proceed, and a phone number that can be used tocontact customer support, etc.

FIG. 29 illustrates an example method for improving or maintaining testcontinuity in the case of network connection issues. When a user beginsa test, the user may be asked at 2902 for their permission to record thetesting session. In some embodiments, this may be a requirement forusing the platform. At 2904, the proctored testing session begins. Thiscan include establishing a live video link between the user and aproctor. At 2906, the platform monitors user's and the proctor's networkconnection. For example, a connection observer can run regularly tomonitor the connection status. In the event that no network connectivityissues are detected, the testing session can be completed as normal. Inthe event that network connectivity issues are detected, at 2908, theplatform may save the test state and/or pause the test. At 2910, arecording of the testing session may be initialized. At 2912, therecording and/or the test state can be stored. Storage can occur locally(e.g., on the user's machine) in the event that the user has lostnetwork connectivity or storage can occur in the cloud if such storagemedium is currently reachable.

At 2914, reconnect procedures may attempt to reestablish connectivitybetween the user and the platform. For example, the platform may attemptto reconnect the user for a predetermined amount of time (also referredto herein as the “reconnect window”). At 2916, if the user cannot bereconnected, the platform moves to 2918 at which the platform evaluateswhether the reconnect window has expired. If it has not, the platformmoves back to 2914. If the reconnect window has expired, the platformmoves to 2920, at which it determines whether proctorless completion ofthe test is possible. Proctorless completion may be possible in somecircumstances depending on the type of test and/or the stage of the testat which connectivity was lost. If proctorless completion is notpossible, the user may be informed at 2922 that the test cannot becompleted. The user will need to retest or resume the test once networkconnectivity is reestablished. If proctorless testing is possible, theuser may be informed of the switch to proctorless mode at 2924. At 2934,the saved test state and/or recorded video can be loaded from the serverand analyzed. At 2936, the test can be resumed from the saved state andcompleted in proctorless mode.

Returning to 2916, if the platform determines that the user isconnected, the platform may, at 2926, determine whether the originalproctor is connected. If the original proctor is connected, the user andproctor can be reconnected and testing can resume as normal. If theoriginal proctor is not connected, at 2930, the user may enter a waitingroom where a new proctor can be assigned. At 2932, the new proctor canaccept the request and the test can be resumed with the new proctor.

Augmented Reality (AR) Based Testing Guidance

In some embodiments, the platform may provide augmented reality (AR)based testing guidance to users and/or proctors. Because users andproctors generally interact with the platform using devices that includedisplays, AR-based testing guidance can be overlaid onto the displays tofacilitate testing and/or proctoring. For example, graphics can beoverlaid onto a live video feed of the test kit (as provided by a cameraof the user's device) to help the user properly open, set up, utilize,and/or dispose of the test kit. As a more specific example, in sometests, the user may be required to deposit drops of a solution onto acertain portion of a test card (see, for example, FIG. 30C, describedbelow). The user can be instructed to position the test kit such that itis within the view of the camera and can be viewed on the user's screen.Guidance indicating where to deposit the drops can be overlaid onto theuser's screen to indicate where the user should place the drops ofsolution. As another example, when the user needs to access a swabwithin the test kit, the location of the swab can be highlighted usingAR on the user's screen.

AR-based guidance can be implemented in a variety of different ways.FIG. 30A illustrates an example set up for providing AR-based guidance.In the illustrated example, a user 3002 accesses the health testing anddiagnostic platform using a smartphone 3004. In this example, thesmartphone 3004 includes both forward facing and rearward facingcameras. One or both of these cameras can be used during a testingprocedure to capture images of, for example, the user 3002 and/or a testkit 3012 used during the testing procedure. Further, the images capturedby the forward and/or rearward facing cameras can be displayed to theuser on a display of the smartphone 3004. Moreover, AR-based guidancecan be added to the images displayed to the user to facilitate andimprove the testing experience. Examples of AR-based guidance that canbe displayed to the user are shown in FIGS. 30C and 30E, describedbelow.

FIG. 30A also illustrates an example set up of the user 3002, thesmartphone 3004, and the test kit 3012, which may be advantageous insome embodiments. In the illustrated example, the user 3002 sits at atable. The test kit 3012 is also positioned on the table in front of theuser. The user's smartphone 3004 is positioned on the table between theuser 3002 and the test kit 3012. In some embodiments, the smartphone3004 is supported by a stand 3006, which can, for example, be acomponent included in the test kit 3012. The smartphone 3004 ispositioned (in some embodiments, with the assistance of the stand 3006)such that the user is visible within the field of view (FOV) 3008 of thesmartphone's forward-facing camera and the test kit 3012 is positionedwithin the FOV 3010 of the smartphone's rearward facing camera. Such aset up may be advantageous as it allows the user 3002 and the test kit3012 to remain within the different FOVs of the forward and rearwardfacing cameras of the smartphone 3002 during the entire testingprocedure. Further, at different portions of the procedure, the outputof the frontward or rearward facing camera can be displayed to the userand supplemented with AR-based guidance.

For example, during one portion of the testing procedure, the output ofthe rearward facing camera (e.g., FOV 3010 in which is positioned thetest kit 3012) can be displayed to the user such that the user can viewthe test kit 3012 on the display of the smartphone 3004. The display canbe updated with AR-based guidance to highlight certain areas of the testkit 3012 or items in the test kit 3012 or overlaid with other types ofinstructions to aid the user in performing the testing procedure. Duringanother portion of the testing procedure, the output of the frontwardfacing camera (e.g., FOV 3008 in which the user 3002 is positioned) canbe displayed to the user such that the user can view his or herself onthe display of the smartphone 3004. The display can be updated withAR-based guidance to highlight certain areas of the user (e.g., anostril) or overlaid with other types of instructions to aid the user inperforming the testing procedure.

In some embodiments, the set up illustrated in FIG. 30A and/or use ofthe stand 3006 can facilitate setting up standard distances between theuser 3002, the user device 3004, and the test kit 3012. In someembodiments, the system may benefit from knowing the distances betweenuser 3002, the user device 3004, and the test kit 3012. For example,knowing these distances may allow the system to more easily identifycertain elements within the field of view(s) 3008, 3012 of the camerasand/or ensure that all steps that must be observed are accuratelycaptured on the camera. In some embodiments, the stand 3006 can beintegrated into the test kit box. For example, a portion of the test kitbox can fold out to provide the stand and fix the distance between thetest kit and the user device.

FIG. 30B illustrates an example in which a user scans a QR code printedon an exterior of a test kit containing test kit materials. In someembodiments, one or more AR features associated with such test kitmaterials may be provided in response to the system scanning the QRcode. For instance, text and/or graphics relating to the test kitmaterials contained within the box on which the QR code is printed maybe overlaid onto the user's screen so as to convey one or more of thefollowing: (i) information about each component stored in the box (e.g.,labeling and/or highlighting various components, displaying text orgraphics beside various components, etc.); and/or (ii) informationregarding the steps that are to be taken by the user in order to take atest using test kit materials contained within the box (e.g., graphicaland/or textual instructions presented in a manner that conveys an orderof operations, etc.). Other types of information can also becommunicated to the user using AR. Although FIG. 30B illustrates a QRcode printed on the test kit box, in some embodiments, the QR code thatis scanned may be printed on one or more of the test kit materials(rather than the box). In some embodiments, other types ofmachine-readable codes (e.g., bar codes, etc.) can be used in additionto or in place of the illustrated QR codes. In some embodiments, one ormore computer vision techniques may be leveraged to identify test kitmaterials and packaging instead of or in addition to the aforementionedQR code scanning techniques.

FIGS. 30C-30E illustrate several examples of AR-based guidance that canbe displayed to a user to facilitate a remote testing procedure. Theillustrated examples are not exhaustive, and AR-based guidance can beused in many other ways as well. In the example of FIG. 30C, the ARgraphics that are overlaid on the screen include a dropper bottle, dropsof solution dripping from the dropper bottle, and a dashed circleoutlining the location where drops are to be applied. Such AR-basedguidance can be used to illustrate to the user the location on a testcard to which a solution should be applied during a testing procedure.In FIG. 30C, textual instructions (e.g., “6 drops,” “Drop the fluid,”etc.) are also overlaid on the screen.

In some embodiments, AR-based guidance may facilitate sample collection.For example, graphics can be overlaid onto a live video feed of the user(as provided by a camera of the user's device) to help the user properlycollect the required biological sample from their person. FIGS. 30D and30E provide examples illustrating AR-based guidance for samplecollection using a nasal swab. In the example of FIG. 30D, the ARgraphics that are overlaid on the screen include a dashed circleoutlining the particular nostril of the user into which a swab is to beinserted. In FIG. 30D, textual instructions (e.g., “5 times,” “Swabnose,” etc.) are also overlaid on the screen. In the example of FIG.30E, the AR graphics that are overlaid on the screen include a curvedarrow indicating the direction in which the user is supposed to swabtheir nostril in a circular motion. In FIG. 30E, textual instructions(e.g., “5 times,” “Swab nose,” etc.) are also overlaid on the screen.

In the case of sample collection via a nasal swab, for example, asillustrated in FIGS. 30D and 30E, images of the user's face can beaugmented with graphics to show the user which nostril to insert theswab (FIG. 30D), the types of movements required to properly collect themucus sample from the nostril (FIG. 30E), the depth to insert swab, etc.Although the figures have illustrated examples of AR-based guidance incases where the user device comprises a smartphone, AR-based guidancecan also be provided for other types of user device. For example, in thecase of a laptop, the aforementioned camera might be a camera on thelaptop located above the screen. In the case of a smartphone, theaforementioned camera might be an inward-facing camera on the front ofthe smartphone above the screen. Accordingly, in some smartphoneembodiments (or other embodiments where the user device includes bothforward- and rearward-facing cameras) some steps may be performed usingthe forward-facing camera and some steps can be performed using therearward-facing camera. The display shown to the user (e.g., on thescreen on the front of the device) can change from the forward- to therearward-facing camera depending on the step being performed. In someembodiments, the change of cameras occurs automatically.

In some examples, the user may place the smartphone in a smartphonestand, and may be instructed to position the test kit in front of thesmartphone such that both the user and the test kit are visible in theinward-facing camera on the front of the smartphone above the screen,for example, as described above with respect to FIG. 30A. With continuedreference to examples where the user accesses the platform using asmartphone, the user may be instructed to seat themselves at a table(with a flat surface), place the test kit on the table about 1.5 to 2feet from the edge of the table, place their smartphone 3004 in asmartphone stand 3006 (e.g., that is included in the test kit), andposition the smartphone 3004 in the smartphone stand 3006 on the tablebetween themselves and the test kit 3002 such that their face and upperbody is within the field of view of the smartphone's inward-facingcamera and the test kit is within the field of the smartphone'soutward-facing camera. Depending on whether the user is being given testkit guidance or sample collection guidance, the live video feed that'sdisplayed for the user and overlaid with graphics may switch between theoutward- and inward-facing cameras.

Artificial Intelligence (AI) Techniques for Proctor Assistance

In some embodiments, the platform may be configured to useproctor-generated data to train an artificial intelligence (AI) system(e.g., a neural network) to facilitate review of test results. Forexample, for each test performed using a live proctor, an image of thephysical test (e.g., as captured by the camera on the user's device uponcompletion of the test and presented to the proctor for interpretation)can be stored in association with the test result as interpreted by theproctor. For example, proctor-classified positive and negative testresult images can be stored. These stored images and the correspondingproctor-determined test results can be used as data for training one ormore neural networks to provide accurate test result interpretations.For example, a single neural network could be trained using datacaptured and generated during proctoring sessions overseen by manydifferent proctors. Alternatively or additionally, a neural networkcould be trained using data captured and generated during proctoringsessions overseen by one specific proctor. Training of the neuralnetwork could be conducted in a training phase, on an ongoing basis, ora combination thereof. In this way, as the platform generates data usinglive proctors, the data set for training the neural network can grow,increasing the accuracy with which the neural network can analyze thetest results.

Once the neural network is sufficiently trained, the neural network can,in some implementations, be used to analyze the test results. In someembodiments, the neural network can be used as a supplement to theproctors' interpretations of the test results. For example, anAI-assisted test result interpretation can be provided to help theproctors analyze the test results. A machine learning model (e.g., theneural network trained in the aforementioned manner) can be used toprovide proctors with recommended suggested test result interpretationsin real-time based on images of physical tests (as captured upon testcompletion and presented to proctors for interpretation). The proctorsmay then be given the option to agree or disagree with eachrecommendation. This may facilitate faster test interpretation by theproctor and/or generate additional data that could be used tocontinually train the neural network.

FIG. 31 is a flowchart illustrating an example method for training anartificial intelligence or machine learning system to interpret testresults according to one embodiment. At 3102, images of test results canbe captured. For example, such images can be taken during a proctoredvideo session. In some embodiments, the images are still images takenfrom a recording of the proctored video session. In some embodiments,the images comprise video of the test results. At 3104, during aproctored testing session, the proctor can view the test results andmake a determination as to whether the results are positive or negative.At 3106, the image of the test result (from 3102) and the determinationmade by the proctor (at 3104) are stored as a result-image pair. At3108, result-image pairs can be used to train an AI or machine learningmodel (such as the neural network described above).

Once the AI model has been trained, the model may, at 3110, presentAI-determined recommendations to the proctors during proctored testsessions. For example, during a proctored test session an image of thetest results can be captured and displayed to the proctor. The image canalso be transmitted to the AI model, which can make a determination asto the result. The AI-determined result can be presented to the proctoras a recommendation. The proctor may make the final determination of theresult based on the image of the test results as well as theAI-determined result. When the proctor determines the result, theresult-image pair may be stored and used to further refine the trainingof the AI model.

Computer Systems

FIG. 32 is a block diagram depicting an embodiment of a computerhardware system configured to run software for implementing one or moreembodiments of the health testing and diagnostic systems, methods, anddevices disclosed herein.

In some embodiments, the systems, processes, and methods describedherein are implemented using a computing system, such as the oneillustrated in FIG. 32. The example computer system 3202 is incommunication with one or more computing systems 3220 and/or one or moredata sources 3222 via one or more networks 3218. While FIG. 32illustrates an embodiment of a computing system 3202, it is recognizedthat the functionality provided for in the components and modules ofcomputer system 3202 may be combined into fewer components and modules,or further separated into additional components and modules.

The computer system 3202 can comprise a health testing and diagnosticmodule 3214 that carries out the functions, methods, acts, and/orprocesses described herein. The health testing and diagnostic module3214 is executed on the computer system 3202 by a central processingunit 3206 discussed further below.

In general, the word “module,” as used herein, refers to logic embodiedin hardware or firmware or to a collection of software instructions,having entry and exit points. Modules are written in a program language,such as JAVA, C or C++, PYPHON or the like. Software modules may becompiled or linked into an executable program, installed in a dynamiclink library, or may be written in an interpreted language such asBASIC, PERL, LUA, or Python. Software modules may be called from othermodules or from themselves, and/or may be invoked in response todetected events or interruptions. Modules implemented in hardwareinclude connected logic units such as gates and flip-flops, and/or mayinclude programmable units, such as programmable gate arrays orprocessors.

Generally, the modules described herein refer to logical modules thatmay be combined with other modules or divided into sub-modules despitetheir physical organization or storage. The modules are executed by oneor more computing systems and may be stored on or within any suitablecomputer readable medium or implemented in-whole or in-part withinspecial designed hardware or firmware. Not all calculations, analysis,and/or optimization require the use of computer systems, though any ofthe above-described methods, calculations, processes, or analyses may befacilitated through the use of computers. Further, in some embodiments,process blocks described herein may be altered, rearranged, combined,and/or omitted.

The computer system 3202 includes one or more processing units (CPU)3206, which may comprise a microprocessor. The computer system 3202further includes a physical memory 3210, such as random access memory(RAM) for temporary storage of information, a read only memory (ROM) forpermanent storage of information, and a mass storage device 3204, suchas a backing store, hard drive, rotating magnetic disks, solid statedisks (SSD), flash memory, phase-change memory (PCM), 3D XPoint memory,diskette, or optical media storage device. Alternatively, the massstorage device may be implemented in an array of servers. Typically, thecomponents of the computer system 3202 are connected to the computerusing a standards-based bus system. The bus system can be implementedusing various protocols, such as Peripheral Component Interconnect(PCI), Micro Channel, SCSI, Industrial Standard Architecture (ISA) andExtended ISA (EISA) architectures.

The computer system 3202 includes one or more input/output (I/O) devicesand interfaces 3212, such as a keyboard, mouse, touch pad, and printer.The I/O devices and interfaces 3212 can include one or more displaydevices, such as a monitor, that allows the visual presentation of datato a user. More particularly, a display device provides for thepresentation of GUIs as application software data, and multi-mediapresentations, for example. The I/O devices and interfaces 3212 can alsoprovide a communications interface to various external devices. Thecomputer system 3202 may comprise one or more multi-media devices 3208,such as speakers, video cards, graphics accelerators, and microphones,for example.

The computer system 3202 may run on a variety of computing devices, suchas a server, a Windows server, a Structure Query Language server, a UnixServer, a personal computer, a laptop computer, and so forth. In otherembodiments, the computer system 3202 may run on a cluster computersystem, a mainframe computer system and/or other computing systemsuitable for controlling and/or communicating with large databases,performing high volume transaction processing, and generating reportsfrom large databases. The computing system 3202 is generally controlledand coordinated by an operating system software, such as z/OS, Windows,Linux, UNIX, BSD, SunOS, Solaris, MacOS, or other compatible operatingsystems, including proprietary operating systems. Operating systemscontrol and schedule computer processes for execution, perform memorymanagement, provide file system, networking, and I/O services, andprovide a user interface, such as a graphical user interface (GUI),among other things.

The computer system 3202 illustrated in FIG. 32 is coupled to a network3218, such as a LAN, WAN, or the Internet via a communication link 3216(wired, wireless, or a combination thereof). Network 3218 communicateswith various computing devices and/or other electronic devices. Network3218 is communicating with one or more computing systems 3220 and one ormore data sources 3222. The health testing and diagnostic module 3214may access or may be accessed by computing systems 3220 and/or datasources 3222 through a web-enabled user access point. Connections may bea direct physical connection, a virtual connection, and other connectiontype. The web-enabled user access point may comprise a browser modulethat uses text, graphics, audio, video, and other media to present dataand to allow interaction with data via the network 3218.

Access to the health testing and diagnostic module 3214 of the computersystem 3202 by computing systems 3220 and/or by data sources 3222 may bethrough a web-enabled user access point such as the computing systems'3220 or data source's 3222 personal computer, cellular phone,smartphone, laptop, tablet computer, e-reader device, audio player, oranother device capable of connecting to the network 3218. Such a devicemay have a browser module that is implemented as a module that usestext, graphics, audio, video, and other media to present data and toallow interaction with data via the network 3218.

The output module may be implemented as a combination of an all-pointsaddressable display such as a cathode ray tube (CRT), a liquid crystaldisplay (LCD), a plasma display, or other types and/or combinations ofdisplays. The output module may be implemented to communicate with inputdevices 3212 and they also include software with the appropriateinterfaces which allow a user to access data through the use of stylizedscreen elements, such as menus, windows, dialogue boxes, tool bars, andcontrols (for example, radio buttons, check boxes, sliding scales, andso forth). Furthermore, the output module may communicate with a set ofinput and output devices to receive signals from the user.

The input device(s) may comprise a keyboard, roller ball, pen andstylus, mouse, trackball, voice recognition system, or pre-designatedswitches or buttons. The output device(s) may comprise a speaker, adisplay screen, a printer, or a voice synthesizer. In addition, a touchscreen may act as a hybrid input/output device. In another embodiment, auser may interact with the system more directly such as through a systemterminal connected to the score generator without communications overthe Internet, a WAN, or LAN, or similar network.

In some embodiments, the system 3202 may comprise a physical or logicalconnection established between a remote microprocessor and a mainframehost computer for the express purpose of uploading, downloading, orviewing interactive data and databases online in real time. The remotemicroprocessor may be operated by an entity operating the computersystem 3202, including the client server systems or the main serversystem, an/or may be operated by one or more of the data sources 3222and/or one or more of the computing systems 3220. In some embodiments,terminal emulation software may be used on the microprocessor forparticipating in the micro-mainframe link.

In some embodiments, computing systems 3220 who are internal to anentity operating the computer system 3202 may access the health testingand diagnostic module 3214 internally as an application or process runby the CPU 3206.

In some embodiments, one or more features of the systems, methods, anddevices described herein can utilize a URL and/or cookies, for examplefor storing and/or transmitting data or user information. A UniformResource Locator (URL) can include a web address and/or a reference to aweb resource that is stored on a database and/or a server. The URL canspecify the location of the resource on a computer and/or a computernetwork. The URL can include a mechanism to retrieve the networkresource. The source of the network resource can receive a URL, identifythe location of the web resource, and transmit the web resource back tothe requestor. A URL can be converted to an IP address, and a DomainName System (DNS) can look up the URL and its corresponding IP address.URLs can be references to web pages, file transfers, emails, databaseaccesses, and other applications. The URLs can include a sequence ofcharacters that identify a path, domain name, a file extension, a hostname, a query, a fragment, scheme, a protocol identifier, a port number,a username, a password, a flag, an object, a resource name and/or thelike. The systems disclosed herein can generate, receive, transmit,apply, parse, serialize, render, and/or perform an action on a URL.

A cookie, also referred to as an HTTP cookie, a web cookie, an internetcookie, and a browser cookie, can include data sent from a websiteand/or stored on a user's computer. This data can be stored by a user'sweb browser while the user is browsing. The cookies can include usefulinformation for websites to remember prior browsing information, such asa shopping cart on an online store, clicking of buttons, logininformation, and/or records of web pages or network resources visited inthe past. Cookies can also include information that the user enters,such as names, addresses, passwords, credit card information, etc.Cookies can also perform computer functions. For example, authenticationcookies can be used by applications (for example, a web browser) toidentify whether the user is already logged in (for example, to a website). The cookie data can be encrypted to provide security for theconsumer. Tracking cookies can be used to compile historical browsinghistories of individuals. Systems disclosed herein can generate and usecookies to access data of an individual. Systems can also generate anduse JSON web tokens to store authenticity information, HTTPauthentication as authentication protocols, IP addresses to tracksession or identity information, URLs, and the like.

The computing system 3202 may include one or more internal and/orexternal data sources (for example, data sources 3222). In someembodiments, one or more of the data repositories and the data sourcesdescribed above may be implemented using a relational database, such asDB2, Sybase, Oracle, CodeBase, and Microsoft® SQL Server as well asother types of databases such as a flat-file database, an entityrelationship database, and object-oriented database, and/or arecord-based database.

The computer system 3202 may also access one or more databases 3222. Thedatabases 3222 may be stored in a database or data repository. Thecomputer system 3202 may access the one or more databases 3222 through anetwork 3218 or may directly access the database or data repositorythrough I/O devices and interfaces 3212. The data repository storing theone or more databases 3222 may reside within the computer system 3202.

FIG. 33 is a block diagram illustrating an example embodiment of acomputer system configured to run software for implementing one or moreembodiments of the health testing and diagnostic systems, methods, anddevices disclosed herein. In some embodiments, the various systems,methods, and devices described herein may also be implemented indecentralized systems such as, for example, blockchain applications. Forexample, blockchain technology may be used to maintain user profiles,proctor profiles, test results, test site databases, and/or financingdatabases or ledgers, dynamically generate, execute, and record testingplan agreements, perform searches, conduct patient-proctor matching,determine pricing, and conduct any other functionalities describedherein.

In some embodiments, a health testing and diagnostic platform 3302 maybe comprised of a registration and purchase module 3304, a testingmodule 3306, an analytics module 3308, and a reporting module 3310. Thehealth testing and diagnostic platform 3302 may also comprise a userprofile database 3312, a proctor database 3314, a test database 3316,and/or a site database 3318. The health testing and diagnostic platform2002 can be connected to a network 3320. The network 3320 can beconfigured to connect the health testing and diagnostic platform 3302 toone or more proctor devices 3322, one or more user devices 3324, one ormore pharmacy systems 3326, one or more third-party provider systems3328, and/or one or more government systems 3330.

The registration and purchase 3304 may function by facilitating patientregistration through one or more registration interfaces and inconjunction with the user database 3312, store user registration data.The testing module 3306 may be configured to allow a user to initiateand complete a medical test or visit with a proctor through a series ofpre-testing and testing interfaces, as described herein. The analyticsmodule 3308 may be configured to dynamically analyze patient testsacross a given population stored in the test database 3316 and providestructured data of the test results. The reporting module 3310 mayfunction by dynamically and automatically reporting test results togovernment entities, patients, and third parties using one or moreinterfaces, such as one or more application programming interfaces. Eachof the modules can be configured to interact with each other and thedatabases discussed herein.

ADDITIONAL EMBODIMENTS

In the foregoing specification, the invention has been described withreference to specific embodiments thereof. It will, however, be evidentthat various modifications and changes may be made thereto withoutdeparting from the broader spirit and scope of the invention. Thespecification and drawings are, accordingly, to be regarded in anillustrative rather than restrictive sense.

Indeed, although this invention has been disclosed in the context ofcertain embodiments and examples, it will be understood by those skilledin the art that the invention extends beyond the specifically disclosedembodiments to other alternative embodiments and/or uses of theinvention and obvious modifications and equivalents thereof. Inaddition, while several variations of the embodiments of the inventionhave been shown and described in detail, other modifications, which arewithin the scope of this invention, will be readily apparent to those ofskill in the art based upon this disclosure. It is also contemplatedthat various combinations or sub-combinations of the specific featuresand aspects of the embodiments may be made and still fall within thescope of the invention. It should be understood that various featuresand aspects of the disclosed embodiments can be combined with, orsubstituted for, one another in order to form varying modes of theembodiments of the disclosed invention. Any methods disclosed hereinneed not be performed in the order recited. Thus, it is intended thatthe scope of the invention herein disclosed should not be limited by theparticular embodiments described above.

It will be appreciated that the systems and methods of the disclosureeach have several innovative aspects, no single one of which is solelyresponsible or required for the desirable attributes disclosed herein.The various features and processes described above may be usedindependently of one another or may be combined in various ways. Allpossible combinations and subcombinations are intended to fall withinthe scope of this disclosure.

Certain features that are described in this specification in the contextof separate embodiments also may be implemented in combination in asingle embodiment. Conversely, various features that are described inthe context of a single embodiment also may be implemented in multipleembodiments separately or in any suitable subcombination. Moreover,although features may be described above as acting in certaincombinations and even initially claimed as such, one or more featuresfrom a claimed combination may in some cases be excised from thecombination, and the claimed combination may be directed to asubcombination or variation of a subcombination. No single feature orgroup of features is necessary or indispensable to each and everyembodiment.

It will also be appreciated that conditional language used herein, suchas, among others, “can,” “could,” “might,” “may,” “e.g.,” and the like,unless specifically stated otherwise, or otherwise understood within thecontext as used, is generally intended to convey that certainembodiments include, while other embodiments do not include, certainfeatures, elements and/or steps. Thus, such conditional language is notgenerally intended to imply that features, elements and/or steps are inany way required for one or more embodiments or that one or moreembodiments necessarily include logic for deciding, with or withoutauthor input or prompting, whether these features, elements and/or stepsare included or are to be performed in any particular embodiment. Theterms “comprising,” “including,” “having,” and the like are synonymousand are used inclusively, in an open-ended fashion, and do not excludeadditional elements, features, acts, operations, and so forth. Inaddition, the term “or” is used in its inclusive sense (and not in itsexclusive sense) so that when used, for example, to connect a list ofelements, the term “or” means one, some, or all of the elements in thelist. In addition, the articles “a,” “an,” and “the” as used in thisapplication and the appended claims are to be construed to mean “one ormore” or “at least one” unless specified otherwise. Similarly, whileoperations may be depicted in the drawings in a particular order, it isto be recognized that such operations need not be performed in theparticular order shown or in sequential order, or that all illustratedoperations be performed, to achieve desirable results. Further, thedrawings may schematically depict one more example processes in the formof a flowchart. However, other operations that are not depicted may beincorporated in the example methods and processes that are schematicallyillustrated. For example, one or more additional operations may beperformed before, after, simultaneously, or between any of theillustrated operations. Additionally, the operations may be rearrangedor reordered in other embodiments. In certain circumstances,multitasking and parallel processing may be advantageous. Moreover, theseparation of various system components in the embodiments describedabove should not be understood as requiring such separation in allembodiments, and it should be understood that the described programcomponents and systems may generally be integrated together in a singlesoftware product or packaged into multiple software products.Additionally, other embodiments are within the scope of the followingclaims. In some cases, the actions recited in the claims may beperformed in a different order and still achieve desirable results.

Further, while the methods and devices described herein may besusceptible to various modifications and alternative forms, specificexamples thereof have been shown in the drawings and are hereindescribed in detail. It should be understood, however, that theinvention is not to be limited to the particular forms or methodsdisclosed, but, to the contrary, the invention is to cover allmodifications, equivalents, and alternatives falling within the spiritand scope of the various implementations described and the appendedclaims. Further, the disclosure herein of any particular feature,aspect, method, property, characteristic, quality, attribute, element,or the like in connection with an implementation or embodiment can beused in all other implementations or embodiments set forth herein. Anymethods disclosed herein need not be performed in the order recited. Themethods disclosed herein may include certain actions taken by apractitioner; however, the methods can also include any third-partyinstruction of those actions, either expressly or by implication. Theranges disclosed herein also encompass any and all overlap, sub-ranges,and combinations thereof. Language such as “up to,” “at least,” “greaterthan,” “less than,” “between,” and the like includes the number recited.Numbers preceded by a term such as “about” or “approximately” includethe recited numbers and should be interpreted based on the circumstances(e.g., as accurate as reasonably possible under the circumstances, forexample ±5%, ±10%, ±15%, etc.). For example, “about 3.5 mm” includes“3.5 mm.” Phrases preceded by a term such as “substantially” include therecited phrase and should be interpreted based on the circumstances(e.g., as much as reasonably possible under the circumstances). Forexample, “substantially constant” includes “constant.” Unless statedotherwise, all measurements are at standard conditions includingtemperature and pressure.

As used herein, a phrase referring to “at least one of” a list of itemsrefers to any combination of those items, including single members. Asan example, “at least one of: A, B, or C” is intended to cover: A, B, C,A and B, A and C, B and C, and A, B, and C. Conjunctive language such asthe phrase “at least one of X, Y and Z,” unless specifically statedotherwise, is otherwise understood with the context as used in generalto convey that an item, term, etc. may be at least one of X, Y or Z.Thus, such conjunctive language is not generally intended to imply thatcertain embodiments require at least one of X, at least one of Y, and atleast one of Z to each be present. The headings provided herein, if any,are for convenience only and do not necessarily affect the scope ormeaning of the devices and methods disclosed herein.

Accordingly, the claims are not intended to be limited to theembodiments shown herein, but are to be accorded the widest scopeconsistent with this disclosure, the principles and the novel featuresdisclosed herein.

1-20. (canceled)
 21. A computer-implemented system for a proctoredexamination platform, the computer-implemented system comprising: anelectronic storage medium comprising computer-executable instructions;one or more processors in electronic communication with the electronicstorage medium and configured to execute the computer-executableinstructions to: receive first image data from a first imaging device ofa user device, the first imaging device comprising a forward facingcamera of the user device, and the first imaging data comprising atleast an image of a user; receive second image data from a secondimaging device of the user, the second imaging device comprising arearward facing camera of the user device, and the second imaging datacomprising an image of a test kit for a medical diagnostic test; duringa medical diagnostic testing procedure, automatically cause one of thefirst image data and the second image data to be displayed on a displayof the user device, wherein the one of the first image data and thesecond image data is selected based on a current step of the medicaldiagnostic testing procedure; generate augmented reality (AR) contentdata associated with the current step of the medical diagnostic test,wherein the AR content data is configured to facilitate performance ofthe current step; and cause the AR content data to be overlaid onto thedisplayed one of the first image data and the second image data.
 22. Thecomputer-implemented system of claim 21, wherein the one or moreprocessors further cause the one of the first image data and the secondimage data to be displayed on a display of a proctor device, whereby aproctor monitors performance of the current step.
 23. Thecomputer-implemented system of claim 22, wherein the AR content data isdisplayed to on the display of the proctor device.
 24. Thecomputer-implemented system of claim 21, wherein the one or moreprocessors further cause both of the first image data and the secondimage data to be displayed on a display of a proctor device, whereby aproctor monitors performance of the current step.
 25. Thecomputer-implemented system of claim 24, wherein the AR content data isdisplayed to on the display of the proctor device.
 26. Thecomputer-implemented system of claim 21, wherein the one or moreprocessors further identify at least one feature within the first imagedata or the second image data, the at least one feature comprising atleast one of an anatomical feature of the user or at least one testingfeature of at least one testing material of the test kit.
 27. Thecomputer-implemented system of claim 26, wherein the AR content data isassociated with the at least one feature.
 28. The computer-implementedsystem of claim 27, wherein the AR content data is overlaid onto the oneof the first image data and the second image data at a position thatcorresponds with the at least one feature.
 29. The computer-implementedsystem of claim 27, wherein the at least one feature comprises one of: anostril of the user, a test swab, and a portion of a testing material towhich a testing solution is to be introduced by the user.
 30. Acomputer-implemented method for a proctored examination platform, thecomputer-implemented method comprising: receiving, by a computer system,first image data from a first imaging device of a user device, the firstimaging device comprising a forward facing camera of the user device,and the first imaging data comprising at least an image of a user;receiving second image data from a second imaging device of the user,the second imaging device comprising a rearward facing camera of theuser device, and the second imaging data comprising an image of a testkit for a medical diagnostic test; during a medical diagnostic testingprocedure, automatically causing one of the first image data and thesecond image data to be displayed on a display of the user device,wherein the one of the first image data and the second image data isselected based on a current step of the medical diagnostic testingprocedure; generating augmented reality (AR) content data associatedwith the current step of the medical diagnostic test, wherein the ARcontent data is configured to facilitate performance of the currentstep; and causing the AR content data to be overlaid onto the displayedone of the first image data and the second image data.
 31. Thecomputer-implemented method of claim 30, further comprising causing theone of the first image data and the second image data to be displayed ona display of a proctor device, whereby a proctor monitors performance ofthe current step.
 32. The computer-implemented method of claim 31,wherein the AR content data is displayed to on the display of theproctor device.
 33. The computer-implemented method of claim 30, furthercomprising causing both of the first image data and the second imagedata to be displayed on a display of a proctor device, whereby a proctormonitors performance of the current step.
 34. The computer-implementedmethod of claim 33, wherein the AR content data is displayed to on thedisplay of the proctor device.
 35. The computer-implemented method ofclaim 30, further comprising identifying at least one feature within thefirst image data or the second image data, the at least one featurecomprising at least one of an anatomical feature of the user or at leastone testing feature of at least one testing material of the test kit.36. The computer-implemented method of claim 35, wherein the AR contentdata is associated with the at least one feature.
 37. Thecomputer-implemented method of claim 36, wherein the AR content data isoverlaid onto the one of the first image data and the second image dataat a position that corresponds with the at least one feature.
 38. Thecomputer-implemented method of claim 37, wherein the at least onefeature comprises one of: a nostril of the user, a test swab, and aportion of a testing material to which a testing solution is to beintroduced by the user.